Target Gene/Pathway Pathway / Gene

---

Search results

---

No.	KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related	KEGG GENES	KEGG DRUG	DrugBank	Disease ID
1	Acute myeloid leukemia 💬	[1] KIT 💬 Acute myeloid leukemia × Name Full Name KIT KIT proto-oncogene, receptor tyrosine kinase	Nilotinib 💬 Acute myeloid leukemia × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 1. Acute myeloid leukemia × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
2	Adipocytokine signaling pathway 💬	[1] NR1C1 💬 Adipocytokine signaling pathway × Name Full Name NR1C1	Fenofibrate 💬 Adipocytokine signaling pathway × Name Other Names Fenofibrate Fenofibrate (JP18/USP/INN) Antara (TN) Lipantil (TN) Lipofen (TN) Tricor (TN) Triglide (TN) ANTARA LIPOFEN TRICOR FENOFIBRATE	Fenofibrate	[6]  8 , 79, 93, 94, 97, 265 💬 2. Adipocytokine signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea; 79 Homozygous familial hypercholesterolemia;Familial hypercholesterolaemia; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 265 Lipodystrophy;
3	Adipocytokine signaling pathway 💬	[2] PRKAA, PRKAA 💬 Adipocytokine signaling pathway × Name Full Name PRKAA PRKAA	Metformin 💬 Adipocytokine signaling pathway × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 3. Adipocytokine signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
4	Adipocytokine signaling pathway 💬	[2] PRKAA, PRKAA 💬 Adipocytokine signaling pathway × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Adipocytokine signaling pathway × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 3. Adipocytokine signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
5	Adrenergic signaling in cardiomyocytes 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬 Adrenergic signaling in cardiomyocytes × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D	Olanzapine 💬 Adrenergic signaling in cardiomyocytes × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 5. Adrenergic signaling in cardiomyocytes × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
6	Adrenergic signaling in cardiomyocytes 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬 Adrenergic signaling in cardiomyocytes × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D	Olanzapine pamoate 💬 Adrenergic signaling in cardiomyocytes × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 5. Adrenergic signaling in cardiomyocytes × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
7	Adrenergic signaling in cardiomyocytes 💬	[8] ADRA1A, ADRA1B, ADRA1D, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Adrenergic signaling in cardiomyocytes × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1 CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Adrenergic signaling in cardiomyocytes × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 7. Adrenergic signaling in cardiomyocytes × Disease ID Name  8  Huntington disease;Huntington chorea;
8	Adrenergic signaling in cardiomyocytes 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Adrenergic signaling in cardiomyocytes × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Adrenergic signaling in cardiomyocytes × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 8. Adrenergic signaling in cardiomyocytes × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
9	Adrenergic signaling in cardiomyocytes 💬	[4] P38, P38, P38, P38 💬 Adrenergic signaling in cardiomyocytes × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Adrenergic signaling in cardiomyocytes × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 9. Adrenergic signaling in cardiomyocytes × Disease ID Name  8  Huntington disease;Huntington chorea;
10	Adrenergic signaling in cardiomyocytes 💬	[1] SCN5A 💬 Adrenergic signaling in cardiomyocytes × Name Full Name SCN5A sodium voltage-gated channel alpha subunit 5	Quinidine gluconate 💬 Adrenergic signaling in cardiomyocytes × Name Other Names Quinidine gluconate Quinidine gluconate (USP) Quinaglute (TN)	Quinidine	[2]  8 , 13 💬 10. Adrenergic signaling in cardiomyocytes × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
11	Adrenergic signaling in cardiomyocytes 💬	[1] SCN5A 💬 Adrenergic signaling in cardiomyocytes × Name Full Name SCN5A sodium voltage-gated channel alpha subunit 5	Quinidine polygalacturonate 💬 Adrenergic signaling in cardiomyocytes × Name Other Names Quinidine polygalacturonate Quinidine polygalacturonate Cardioquin (TN)	Quinidine	[2]  8 , 13 💬 10. Adrenergic signaling in cardiomyocytes × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
12	Adrenergic signaling in cardiomyocytes 💬	[1] SCN5A 💬 Adrenergic signaling in cardiomyocytes × Name Full Name SCN5A sodium voltage-gated channel alpha subunit 5	Quinidine sulfate 💬 Adrenergic signaling in cardiomyocytes × Name Other Names Quinidine sulfate Quinidine sulfate (USP) Quinidine sulfate hydrate (JP18) Quinidex (TN)	Quinidine	[2]  8 , 13 💬 10. Adrenergic signaling in cardiomyocytes × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
13	Adrenergic signaling in cardiomyocytes 💬	[1] SCN5A 💬 Adrenergic signaling in cardiomyocytes × Name Full Name SCN5A sodium voltage-gated channel alpha subunit 5	Quinidine 💬 Adrenergic signaling in cardiomyocytes × Name Other Names Quinidine Quinidine (BAN) Kinidin (TN)	Quinidine	[2]  8 , 13 💬 10. Adrenergic signaling in cardiomyocytes × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
14	AGE-RAGE signaling pathway in diabetic complications 💬	[4] P38, P38, P38, P38 💬 AGE-RAGE signaling pathway in diabetic complications × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 AGE-RAGE signaling pathway in diabetic complications × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 14. AGE-RAGE signaling pathway in diabetic complications × Disease ID Name  8  Huntington disease;Huntington chorea;
15	Alcoholic liver disease 💬	[1] NR1C1 💬 Alcoholic liver disease × Name Full Name NR1C1	Fenofibrate 💬 Alcoholic liver disease × Name Other Names Fenofibrate Fenofibrate (JP18/USP/INN) Antara (TN) Lipantil (TN) Lipofen (TN) Tricor (TN) Triglide (TN) ANTARA LIPOFEN TRICOR FENOFIBRATE	Fenofibrate	[6]  8 , 79, 93, 94, 97, 265 💬 15. Alcoholic liver disease × Disease ID Name  8  Huntington disease;Huntington chorea; 79 Homozygous familial hypercholesterolemia;Familial hypercholesterolaemia; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 265 Lipodystrophy;
16	Alcoholic liver disease 💬	[4] P38, P38, P38, P38 💬 Alcoholic liver disease × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Alcoholic liver disease × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 16. Alcoholic liver disease × Disease ID Name  8  Huntington disease;Huntington chorea;
17	Alcoholic liver disease 💬	[2] PRKAA, PRKAA 💬 Alcoholic liver disease × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Alcoholic liver disease × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 17. Alcoholic liver disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
18	Alcoholic liver disease 💬	[2] PRKAA, PRKAA 💬 Alcoholic liver disease × Name Full Name PRKAA PRKAA	Metformin 💬 Alcoholic liver disease × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 17. Alcoholic liver disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
19	Alcoholism 💬	[1] DRD2 💬 Alcoholism × Name Full Name DRD2 dopamine receptor D2	Haloperidol 💬 Alcoholism × Name Other Names Haloperidol Haloperidol (JP18/USP/INN) Haldol (TN)	Haloperidol	[1]  8  💬 19. Alcoholism × Disease ID Name  8  Huntington disease;Huntington chorea;
20	Alcoholism 💬	[1] DRD2 💬 Alcoholism × Name Full Name DRD2 dopamine receptor D2	Haloperidol decanoate 💬 Alcoholism × Name Other Names Haloperidol decanoate Haloperidol decanoate (JAN/USP) Halomonth (TN) HALDOL DECANOATE HALOPERIDOL DECANOATE	Haloperidol	[1]  8  💬 19. Alcoholism × Disease ID Name  8  Huntington disease;Huntington chorea;
21	Alcoholism 💬	[1] DRD2 💬 Alcoholism × Name Full Name DRD2 dopamine receptor D2	Haloperidol lactate 💬 Alcoholism × Name Other Names Haloperidol lactate Haloperidol lactate Haldol (TN)	Haloperidol	[1]  8  💬 19. Alcoholism × Disease ID Name  8  Huntington disease;Huntington chorea;
22	Alcoholism 💬	[1] DRD2 💬 Alcoholism × Name Full Name DRD2 dopamine receptor D2	Olanzapine 💬 Alcoholism × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 22. Alcoholism × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
23	Alcoholism 💬	[1] DRD2 💬 Alcoholism × Name Full Name DRD2 dopamine receptor D2	Olanzapine pamoate 💬 Alcoholism × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 22. Alcoholism × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
24	Alcoholism 💬	[1] DRD2 💬 Alcoholism × Name Full Name DRD2 dopamine receptor D2	Pridopidine 💬 Alcoholism × Name Other Names Pridopidine Pridopidine (USAN/INN)	Pridopidine	[3]  2 ,  6 ,  8  💬 24. Alcoholism × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
25	Alcoholism 💬	[1] DRD2 💬 Alcoholism × Name Full Name DRD2 dopamine receptor D2	Pridopidine hydrochloride 💬 Alcoholism × Name Other Names Pridopidine hydrochloride Pridopidine hydrochloride (USAN)	Pridopidine	[3]  2 ,  6 ,  8  💬 24. Alcoholism × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
26	Alcoholism 💬	[1] DRD2 💬 Alcoholism × Name Full Name DRD2 dopamine receptor D2	Risperidone 💬 Alcoholism × Name Other Names Risperidone Risperidone (JP18/USP/INN) Risperdal (TN) PERSERIS RISPERDAL CONSTA RISPERIDONE RYKINDO UZEDY	Risperidone	[3]  8 , 156, 187 💬 26. Alcoholism × Disease ID Name  8  Huntington disease;Huntington chorea; 156 Rett syndrome; 187 Kabuki syndrome;
27	Alcoholism 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alcoholism × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Alcoholism × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 27. Alcoholism × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
28	Alcoholism 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alcoholism × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Alcoholism × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 27. Alcoholism × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
29	Alcoholism 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alcoholism × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan hydrobromide 💬 Alcoholism × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 29. Alcoholism × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
30	Alcoholism 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alcoholism × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan 💬 Alcoholism × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 29. Alcoholism × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
31	Alcoholism 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alcoholism × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Alcoholism × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 31. Alcoholism × Disease ID Name  8  Huntington disease;Huntington chorea;
32	Alcoholism 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alcoholism × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Alcoholism × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 31. Alcoholism × Disease ID Name  8  Huntington disease;Huntington chorea;
33	Alcoholism 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alcoholism × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Alcoholism × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 33. Alcoholism × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
34	Alcoholism 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alcoholism × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Alcoholism × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 33. Alcoholism × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
35	Alcoholism 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alcoholism × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Alcoholism × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 35. Alcoholism × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
36	Alcoholism 💬	[1] SLC18A1_2 💬 Alcoholism × Name Full Name SLC18A1_2	Deutetrabenazine 💬 Alcoholism × Name Other Names Deutetrabenazine Deutetrabenazine (USAN/INN) Austedo (TN) DEUTETRABENAZINE	Deutetrabenazine	[1]  8  💬 36. Alcoholism × Disease ID Name  8  Huntington disease;Huntington chorea;
37	Alcoholism 💬	[1] SLC18A1_2 💬 Alcoholism × Name Full Name SLC18A1_2	Tetrabenazine 💬 Alcoholism × Name Other Names Tetrabenazine Tetrabenazine (JAN/INN) Nitoman (TN) Xenazine (TN) XENAZINE TETRABENAZINE	Tetrabenazine	[1]  8  💬 37. Alcoholism × Disease ID Name  8  Huntington disease;Huntington chorea;
38	Alcoholism 💬	[1] SLC18A1_2 💬 Alcoholism × Name Full Name SLC18A1_2	Valbenazine 💬 Alcoholism × Name Other Names Valbenazine Valbenazine (USAN/INN)	Valbenazine	[1]  8  💬 38. Alcoholism × Disease ID Name  8  Huntington disease;Huntington chorea;
39	Alcoholism 💬	[1] SLC18A1_2 💬 Alcoholism × Name Full Name SLC18A1_2	Valbenazine tosylate 💬 Alcoholism × Name Other Names Valbenazine tosylate Valbenazine tosylate (USAN) Valbenazine tosilate (JAN) Valbenazine ditosylate Ingrezza (TN) Dysval (TN) VALBENAZINE	Valbenazine	[1]  8  💬 38. Alcoholism × Disease ID Name  8  Huntington disease;Huntington chorea;
40	Alcoholism 💬	[1] SLC6A3 💬 Alcoholism × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion hydrochloride 💬 Alcoholism × Name Other Names Bupropion hydrochloride Bupropion hydrochloride (JAN/USP) Wellbutrin (TN) Zyban (TN) FORFIVO WELLBUTRIN BUPROPION BUPROPION HCL BUPROPION HCL ER BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE SR	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 40. Alcoholism × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
41	Alcoholism 💬	[1] SLC6A3 💬 Alcoholism × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion 💬 Alcoholism × Name Other Names Bupropion Bupropion (INN)	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 40. Alcoholism × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
42	Alcoholism 💬	[1] SLC6A3 💬 Alcoholism × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion hydrobromide 💬 Alcoholism × Name Other Names Bupropion hydrobromide Bupropion hydrobromide (USAN) Aplenzin (TN) APLENZIN	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 40. Alcoholism × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
43	Aldosterone synthesis and secretion 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Aldosterone synthesis and secretion × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Aldosterone synthesis and secretion × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 43. Aldosterone synthesis and secretion × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
44	Aldosterone synthesis and secretion 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Aldosterone synthesis and secretion × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Aldosterone synthesis and secretion × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 44. Aldosterone synthesis and secretion × Disease ID Name  8  Huntington disease;Huntington chorea;
45	Aldosterone-regulated sodium reabsorption 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Aldosterone-regulated sodium reabsorption × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Aldosterone-regulated sodium reabsorption × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 45. Aldosterone-regulated sodium reabsorption × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
46	Alzheimer disease 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Alzheimer disease × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Alzheimer disease × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 46. Alzheimer disease × Disease ID Name  8  Huntington disease;Huntington chorea;
47	Alzheimer disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alzheimer disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Alzheimer disease × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 47. Alzheimer disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
48	Alzheimer disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alzheimer disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Alzheimer disease × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 47. Alzheimer disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
49	Alzheimer disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alzheimer disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan hydrobromide 💬 Alzheimer disease × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 49. Alzheimer disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
50	Alzheimer disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alzheimer disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan 💬 Alzheimer disease × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 49. Alzheimer disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
51	Alzheimer disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alzheimer disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Alzheimer disease × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 51. Alzheimer disease × Disease ID Name  8  Huntington disease;Huntington chorea;
52	Alzheimer disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alzheimer disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Alzheimer disease × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 51. Alzheimer disease × Disease ID Name  8  Huntington disease;Huntington chorea;
53	Alzheimer disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alzheimer disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Alzheimer disease × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 53. Alzheimer disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
54	Alzheimer disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alzheimer disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Alzheimer disease × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 53. Alzheimer disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
55	Alzheimer disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Alzheimer disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Alzheimer disease × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 55. Alzheimer disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
56	Amphetamine addiction 💬	[2] CACNA1C, CACNA1D 💬 Amphetamine addiction × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D	Bevantolol hydrochloride 💬 Amphetamine addiction × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 56. Amphetamine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
57	Amphetamine addiction 💬	[9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amphetamine addiction × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIA3 glutamate ionotropic receptor AMPA type subunit 3 GRIA4 glutamate ionotropic receptor AMPA type subunit 4 GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Amphetamine addiction × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 57. Amphetamine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
58	Amphetamine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amphetamine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Amphetamine addiction × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 58. Amphetamine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
59	Amphetamine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amphetamine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Amphetamine addiction × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 58. Amphetamine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
60	Amphetamine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amphetamine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan hydrobromide 💬 Amphetamine addiction × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 60. Amphetamine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
61	Amphetamine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amphetamine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan 💬 Amphetamine addiction × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 60. Amphetamine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
62	Amphetamine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amphetamine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Amphetamine addiction × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 62. Amphetamine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
63	Amphetamine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amphetamine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Amphetamine addiction × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 62. Amphetamine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
64	Amphetamine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amphetamine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Amphetamine addiction × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 64. Amphetamine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
65	Amphetamine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amphetamine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Amphetamine addiction × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 64. Amphetamine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
66	Amphetamine addiction 💬	[1] SLC18A1_2 💬 Amphetamine addiction × Name Full Name SLC18A1_2	Deutetrabenazine 💬 Amphetamine addiction × Name Other Names Deutetrabenazine Deutetrabenazine (USAN/INN) Austedo (TN) DEUTETRABENAZINE	Deutetrabenazine	[1]  8  💬 66. Amphetamine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
67	Amphetamine addiction 💬	[1] SLC18A1_2 💬 Amphetamine addiction × Name Full Name SLC18A1_2	Tetrabenazine 💬 Amphetamine addiction × Name Other Names Tetrabenazine Tetrabenazine (JAN/INN) Nitoman (TN) Xenazine (TN) XENAZINE TETRABENAZINE	Tetrabenazine	[1]  8  💬 67. Amphetamine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
68	Amphetamine addiction 💬	[1] SLC18A1_2 💬 Amphetamine addiction × Name Full Name SLC18A1_2	Valbenazine 💬 Amphetamine addiction × Name Other Names Valbenazine Valbenazine (USAN/INN)	Valbenazine	[1]  8  💬 68. Amphetamine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
69	Amphetamine addiction 💬	[1] SLC18A1_2 💬 Amphetamine addiction × Name Full Name SLC18A1_2	Valbenazine tosylate 💬 Amphetamine addiction × Name Other Names Valbenazine tosylate Valbenazine tosylate (USAN) Valbenazine tosilate (JAN) Valbenazine ditosylate Ingrezza (TN) Dysval (TN) VALBENAZINE	Valbenazine	[1]  8  💬 68. Amphetamine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
70	Amphetamine addiction 💬	[1] SLC6A3 💬 Amphetamine addiction × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion hydrochloride 💬 Amphetamine addiction × Name Other Names Bupropion hydrochloride Bupropion hydrochloride (JAN/USP) Wellbutrin (TN) Zyban (TN) FORFIVO WELLBUTRIN BUPROPION BUPROPION HCL BUPROPION HCL ER BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE SR	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 70. Amphetamine addiction × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
71	Amphetamine addiction 💬	[1] SLC6A3 💬 Amphetamine addiction × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion 💬 Amphetamine addiction × Name Other Names Bupropion Bupropion (INN)	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 70. Amphetamine addiction × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
72	Amphetamine addiction 💬	[1] SLC6A3 💬 Amphetamine addiction × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion hydrobromide 💬 Amphetamine addiction × Name Other Names Bupropion hydrobromide Bupropion hydrobromide (USAN) Aplenzin (TN) APLENZIN	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 70. Amphetamine addiction × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
73	AMPK signaling pathway 💬	[1] ADRA1A 💬 AMPK signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A	Bevantolol hydrochloride 💬 AMPK signaling pathway × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 73. AMPK signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
74	AMPK signaling pathway 💬	[1] ADRA1A 💬 AMPK signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A	Olanzapine 💬 AMPK signaling pathway × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 74. AMPK signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
75	AMPK signaling pathway 💬	[1] ADRA1A 💬 AMPK signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A	Olanzapine pamoate 💬 AMPK signaling pathway × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 74. AMPK signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
76	AMPK signaling pathway 💬	[2] PRKAA, PRKAA 💬 AMPK signaling pathway × Name Full Name PRKAA PRKAA	Metformin 💬 AMPK signaling pathway × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 76. AMPK signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
77	AMPK signaling pathway 💬	[2] PRKAA, PRKAA 💬 AMPK signaling pathway × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 AMPK signaling pathway × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 76. AMPK signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
78	Amyotrophic lateral sclerosis 💬	[7] GRIA1, GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amyotrophic lateral sclerosis × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Amyotrophic lateral sclerosis × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 78. Amyotrophic lateral sclerosis × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
79	Amyotrophic lateral sclerosis 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amyotrophic lateral sclerosis × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Amyotrophic lateral sclerosis × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 79. Amyotrophic lateral sclerosis × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
80	Amyotrophic lateral sclerosis 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amyotrophic lateral sclerosis × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Amyotrophic lateral sclerosis × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 79. Amyotrophic lateral sclerosis × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
81	Amyotrophic lateral sclerosis 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amyotrophic lateral sclerosis × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Amyotrophic lateral sclerosis × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 81. Amyotrophic lateral sclerosis × Disease ID Name  8  Huntington disease;Huntington chorea;
82	Amyotrophic lateral sclerosis 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amyotrophic lateral sclerosis × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Amyotrophic lateral sclerosis × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 81. Amyotrophic lateral sclerosis × Disease ID Name  8  Huntington disease;Huntington chorea;
83	Amyotrophic lateral sclerosis 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amyotrophic lateral sclerosis × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Amyotrophic lateral sclerosis × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 83. Amyotrophic lateral sclerosis × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
84	Amyotrophic lateral sclerosis 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Amyotrophic lateral sclerosis × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Amyotrophic lateral sclerosis × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 83. Amyotrophic lateral sclerosis × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
85	Amyotrophic lateral sclerosis 💬	[6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 Amyotrophic lateral sclerosis × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D SIGMAR1 sigma non-opioid intracellular receptor 1	Dextromethorphan hydrobromide 💬 Amyotrophic lateral sclerosis × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 85. Amyotrophic lateral sclerosis × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
86	Amyotrophic lateral sclerosis 💬	[6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 Amyotrophic lateral sclerosis × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D SIGMAR1 sigma non-opioid intracellular receptor 1	Dextromethorphan 💬 Amyotrophic lateral sclerosis × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 85. Amyotrophic lateral sclerosis × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
87	Amyotrophic lateral sclerosis 💬	[4] P38, P38, P38, P38 💬 Amyotrophic lateral sclerosis × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Amyotrophic lateral sclerosis × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 87. Amyotrophic lateral sclerosis × Disease ID Name  8  Huntington disease;Huntington chorea;
88	Apelin signaling pathway 💬	[2] PRKAA, PRKAA 💬 Apelin signaling pathway × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Apelin signaling pathway × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 88. Apelin signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
89	Apelin signaling pathway 💬	[2] PRKAA, PRKAA 💬 Apelin signaling pathway × Name Full Name PRKAA PRKAA	Metformin 💬 Apelin signaling pathway × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 88. Apelin signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
90	Arrhythmogenic right ventricular cardiomyopathy 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Arrhythmogenic right ventricular cardiomyopathy × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Arrhythmogenic right ventricular cardiomyopathy × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 90. Arrhythmogenic right ventricular cardiomyopathy × Disease ID Name  8  Huntington disease;Huntington chorea;
91	Autophagy - animal 💬	[2] PRKAA, PRKAA 💬 Autophagy - animal × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Autophagy - animal × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 91. Autophagy - animal × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
92	Autophagy - animal 💬	[2] PRKAA, PRKAA 💬 Autophagy - animal × Name Full Name PRKAA PRKAA	Metformin 💬 Autophagy - animal × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 91. Autophagy - animal × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
93	Axon guidance 💬	[1] ABL1 💬 Axon guidance × Name Full Name ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase	Nilotinib 💬 Axon guidance × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 93. Axon guidance × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
94	Bile secretion 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Bile secretion × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Bile secretion × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 94. Bile secretion × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
95	Bile secretion 💬	[1] NR1H4 💬 Bile secretion × Name Full Name NR1H4 nuclear receptor subfamily 1 group H member 4	Ursodiol 💬 Bile secretion × Name Other Names Ursodiol Ursodiol (USP) Ursodeoxycholic acid (JP18/INN) Actigall (TN) Urso (TN) URSODIOL USODIOL	Ursodeoxycholic acid	[14]  6 ,  8 , 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 💬 95. Bile secretion × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 84 Sarcoidosis; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 95 Autoimmune hepatitis; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 234 Peroxisomal disease (except Adrenoleukodystrophy);Peroxisomal disease;Peroxisomal disorder;Peroxisome biogenesis disorder;Contiguous ABCD1/DXS1357E deletion syndrome;CADDS;Peroxisome biogenesis disorder;PBD;PEX gene disorder;Zellweger syndrome;Neonatal adrenoleukodystrophy;Infantile Refsum disease;Rhizomelic chondrodysplasia punctata type 1;RCDP type 1;RCDP1;Peroxisomal beta-oxidation enzyme deficiency;Acyl-CoA oxidase deficiency;AOX deficiency;D-Bifunctional protein deficiency;DBP deficiency;Sterol carrier protein X deficiency;SCPx deficiency;2-methylacyl-CoA racemase deficiency;Alpha-methylacyl-CoA racemase deficiency;AMACR deficiency;Plasmalogen biosynthesis enzyme deficiency;Rhizomelic chondrodysplasia punctata type 2;RCDP type 2;RCDP2;Rhizomelic chondrodysplasia punctata type 3;RCDP type 3;RCDP3;Refsum disease;Primary hyperoxaluria type 1;PH1;Primary hyperoxaluria;Acatalasemia;Acatalasia;Takahara disease; 296 Biliary atresia; 299 Cystic fibrosis;CF;
96	Breast cancer 💬	[1] KIT 💬 Breast cancer × Name Full Name KIT KIT proto-oncogene, receptor tyrosine kinase	Nilotinib 💬 Breast cancer × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 96. Breast cancer × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
97	C-type lectin receptor signaling pathway 💬	[4] P38, P38, P38, P38 💬 C-type lectin receptor signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 C-type lectin receptor signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 97. C-type lectin receptor signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
98	Calcium signaling pathway 💬	[8] ADRA1A, ADRA1B, ADRA1D, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Calcium signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1 CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Calcium signaling pathway × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 98. Calcium signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
99	Calcium signaling pathway 💬	[8] ADRA1A, ADRA1B, ADRA1D, HRH1, HTR2, HTR2, HTR2, HTR6 💬 Calcium signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D HRH1 histamine receptor H1 HTR2 HTR2 HTR2 HTR6 5-hydroxytryptamine receptor 6	Olanzapine pamoate 💬 Calcium signaling pathway × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 99. Calcium signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
100	Calcium signaling pathway 💬	[8] ADRA1A, ADRA1B, ADRA1D, HRH1, HTR2, HTR2, HTR2, HTR6 💬 Calcium signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D HRH1 histamine receptor H1 HTR2 HTR2 HTR2 HTR6 5-hydroxytryptamine receptor 6	Olanzapine 💬 Calcium signaling pathway × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 99. Calcium signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
101	Calcium signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Calcium signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Calcium signaling pathway × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 101. Calcium signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
102	Calcium signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Calcium signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Calcium signaling pathway × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 101. Calcium signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
103	Calcium signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Calcium signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan hydrobromide 💬 Calcium signaling pathway × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 103. Calcium signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
104	Calcium signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Calcium signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan 💬 Calcium signaling pathway × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 103. Calcium signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
105	Calcium signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Calcium signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Calcium signaling pathway × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 105. Calcium signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
106	Calcium signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Calcium signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Calcium signaling pathway × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 105. Calcium signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
107	Calcium signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Calcium signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Calcium signaling pathway × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 107. Calcium signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
108	Calcium signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Calcium signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Calcium signaling pathway × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 107. Calcium signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
109	Calcium signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Calcium signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Calcium signaling pathway × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 109. Calcium signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
110	Calcium signaling pathway 💬	[1] HTR2 💬 Calcium signaling pathway × Name Full Name HTR2	Risperidone 💬 Calcium signaling pathway × Name Other Names Risperidone Risperidone (JP18/USP/INN) Risperdal (TN) PERSERIS RISPERDAL CONSTA RISPERIDONE RYKINDO UZEDY	Risperidone	[3]  8 , 156, 187 💬 110. Calcium signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea; 156 Rett syndrome; 187 Kabuki syndrome;
111	Calcium signaling pathway 💬	[2] PDGFRA, PDGFRB 💬 Calcium signaling pathway × Name Full Name PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 Calcium signaling pathway × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 111. Calcium signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
112	cAMP signaling pathway 💬	[5] ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 cAMP signaling pathway × Name Full Name ADRB1 adrenoceptor beta 1 CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 cAMP signaling pathway × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 112. cAMP signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
113	cAMP signaling pathway 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 cAMP signaling pathway × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 cAMP signaling pathway × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 113. cAMP signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
114	cAMP signaling pathway 💬	[1] DRD2 💬 cAMP signaling pathway × Name Full Name DRD2 dopamine receptor D2	Haloperidol 💬 cAMP signaling pathway × Name Other Names Haloperidol Haloperidol (JP18/USP/INN) Haldol (TN)	Haloperidol	[1]  8  💬 114. cAMP signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
115	cAMP signaling pathway 💬	[1] DRD2 💬 cAMP signaling pathway × Name Full Name DRD2 dopamine receptor D2	Haloperidol decanoate 💬 cAMP signaling pathway × Name Other Names Haloperidol decanoate Haloperidol decanoate (JAN/USP) Halomonth (TN) HALDOL DECANOATE HALOPERIDOL DECANOATE	Haloperidol	[1]  8  💬 114. cAMP signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
116	cAMP signaling pathway 💬	[1] DRD2 💬 cAMP signaling pathway × Name Full Name DRD2 dopamine receptor D2	Haloperidol lactate 💬 cAMP signaling pathway × Name Other Names Haloperidol lactate Haloperidol lactate Haldol (TN)	Haloperidol	[1]  8  💬 114. cAMP signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
117	cAMP signaling pathway 💬	[1] DRD2 💬 cAMP signaling pathway × Name Full Name DRD2 dopamine receptor D2	Pridopidine 💬 cAMP signaling pathway × Name Other Names Pridopidine Pridopidine (USAN/INN)	Pridopidine	[3]  2 ,  6 ,  8  💬 117. cAMP signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
118	cAMP signaling pathway 💬	[1] DRD2 💬 cAMP signaling pathway × Name Full Name DRD2 dopamine receptor D2	Pridopidine hydrochloride 💬 cAMP signaling pathway × Name Other Names Pridopidine hydrochloride Pridopidine hydrochloride (USAN)	Pridopidine	[3]  2 ,  6 ,  8  💬 117. cAMP signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
119	cAMP signaling pathway 💬	[1] DRD2 💬 cAMP signaling pathway × Name Full Name DRD2 dopamine receptor D2	Risperidone 💬 cAMP signaling pathway × Name Other Names Risperidone Risperidone (JP18/USP/INN) Risperdal (TN) PERSERIS RISPERDAL CONSTA RISPERIDONE RYKINDO UZEDY	Risperidone	[3]  8 , 156, 187 💬 119. cAMP signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea; 156 Rett syndrome; 187 Kabuki syndrome;
120	cAMP signaling pathway 💬	[2] DRD2, HTR6 💬 cAMP signaling pathway × Name Full Name DRD2 dopamine receptor D2 HTR6 5-hydroxytryptamine receptor 6	Olanzapine 💬 cAMP signaling pathway × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 120. cAMP signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
121	cAMP signaling pathway 💬	[2] DRD2, HTR6 💬 cAMP signaling pathway × Name Full Name DRD2 dopamine receptor D2 HTR6 5-hydroxytryptamine receptor 6	Olanzapine pamoate 💬 cAMP signaling pathway × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 120. cAMP signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
122	cAMP signaling pathway 💬	[9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 cAMP signaling pathway × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIA3 glutamate ionotropic receptor AMPA type subunit 3 GRIA4 glutamate ionotropic receptor AMPA type subunit 4 GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 cAMP signaling pathway × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 122. cAMP signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
123	cAMP signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 cAMP signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 cAMP signaling pathway × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 123. cAMP signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
124	cAMP signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 cAMP signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 cAMP signaling pathway × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 123. cAMP signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
125	cAMP signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 cAMP signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan hydrobromide 💬 cAMP signaling pathway × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 125. cAMP signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
126	cAMP signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 cAMP signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan 💬 cAMP signaling pathway × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 125. cAMP signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
127	cAMP signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 cAMP signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 cAMP signaling pathway × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 127. cAMP signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
128	cAMP signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 cAMP signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 cAMP signaling pathway × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 127. cAMP signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
129	cAMP signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 cAMP signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 cAMP signaling pathway × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 129. cAMP signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
130	cAMP signaling pathway 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 cAMP signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 cAMP signaling pathway × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 129. cAMP signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
131	cAMP signaling pathway 💬	[1] NR1C1 💬 cAMP signaling pathway × Name Full Name NR1C1	Fenofibrate 💬 cAMP signaling pathway × Name Other Names Fenofibrate Fenofibrate (JP18/USP/INN) Antara (TN) Lipantil (TN) Lipofen (TN) Tricor (TN) Triglide (TN) ANTARA LIPOFEN TRICOR FENOFIBRATE	Fenofibrate	[6]  8 , 79, 93, 94, 97, 265 💬 131. cAMP signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea; 79 Homozygous familial hypercholesterolemia;Familial hypercholesterolaemia; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 265 Lipodystrophy;
132	cAMP signaling pathway 💬	[4] PDE4, PDE4, PDE4, PDE4 💬 cAMP signaling pathway × Name Full Name PDE4 PDE4 PDE4 PDE4	Rolipram 💬 cAMP signaling pathway × Name Other Names Rolipram Rolipram (JAN/USAN/INN)	Rolipram	[2]  8 , 13 💬 132. cAMP signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
133	Carbohydrate digestion and absorption 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Carbohydrate digestion and absorption × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Carbohydrate digestion and absorption × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 133. Carbohydrate digestion and absorption × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
134	Carbohydrate digestion and absorption 💬	[1] CACNA1D 💬 Carbohydrate digestion and absorption × Name Full Name CACNA1D calcium voltage-gated channel subunit alpha1 D	Bevantolol hydrochloride 💬 Carbohydrate digestion and absorption × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 134. Carbohydrate digestion and absorption × Disease ID Name  8  Huntington disease;Huntington chorea;
135	Cardiac muscle contraction 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Cardiac muscle contraction × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Cardiac muscle contraction × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 135. Cardiac muscle contraction × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
136	Cardiac muscle contraction 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Cardiac muscle contraction × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Cardiac muscle contraction × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 136. Cardiac muscle contraction × Disease ID Name  8  Huntington disease;Huntington chorea;
137	Cell cycle 💬	[1] ABL1 💬 Cell cycle × Name Full Name ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase	Nilotinib 💬 Cell cycle × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 137. Cell cycle × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
138	Cellular senescence 💬	[1] CACNA1D 💬 Cellular senescence × Name Full Name CACNA1D calcium voltage-gated channel subunit alpha1 D	Bevantolol hydrochloride 💬 Cellular senescence × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 138. Cellular senescence × Disease ID Name  8  Huntington disease;Huntington chorea;
139	Cellular senescence 💬	[4] P38, P38, P38, P38 💬 Cellular senescence × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Cellular senescence × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 139. Cellular senescence × Disease ID Name  8  Huntington disease;Huntington chorea;
140	Central carbon metabolism in cancer 💬	[3] KIT, PDGFRA, PDGFRB 💬 Central carbon metabolism in cancer × Name Full Name KIT KIT proto-oncogene, receptor tyrosine kinase PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 Central carbon metabolism in cancer × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 140. Central carbon metabolism in cancer × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
141	cGMP-PKG signaling pathway 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬 cGMP-PKG signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D	Olanzapine 💬 cGMP-PKG signaling pathway × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 141. cGMP-PKG signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
142	cGMP-PKG signaling pathway 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬 cGMP-PKG signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D	Olanzapine pamoate 💬 cGMP-PKG signaling pathway × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 141. cGMP-PKG signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
143	cGMP-PKG signaling pathway 💬	[8] ADRA1A, ADRA1B, ADRA1D, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 cGMP-PKG signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1 CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 cGMP-PKG signaling pathway × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 143. cGMP-PKG signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
144	cGMP-PKG signaling pathway 💬	[3] ADRA2A, ADRA2B, ADRA2C 💬 cGMP-PKG signaling pathway × Name Full Name ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C	Rilmenidine 💬 cGMP-PKG signaling pathway × Name Other Names Rilmenidine Rilmenidine (INN) Hyperium (TN)	Rilmenidine	[1]  8  💬 144. cGMP-PKG signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
145	cGMP-PKG signaling pathway 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 cGMP-PKG signaling pathway × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 cGMP-PKG signaling pathway × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 145. cGMP-PKG signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
146	Chagas disease 💬	[4] P38, P38, P38, P38 💬 Chagas disease × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Chagas disease × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 146. Chagas disease × Disease ID Name  8  Huntington disease;Huntington chorea;
147	Chemical carcinogenesis - reactive oxygen species 💬	[1] ABL1 💬 Chemical carcinogenesis - reactive oxygen species × Name Full Name ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase	Nilotinib 💬 Chemical carcinogenesis - reactive oxygen species × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 147. Chemical carcinogenesis - reactive oxygen species × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
148	Chemical carcinogenesis - reactive oxygen species 💬	[1] NQO1 💬 Chemical carcinogenesis - reactive oxygen species × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1	Warfarin sodium 💬 Chemical carcinogenesis - reactive oxygen species × Name Other Names Warfarin sodium Warfarin sodium (USP) Coumadin (TN) Jantoven (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 148. Chemical carcinogenesis - reactive oxygen species × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
149	Chemical carcinogenesis - reactive oxygen species 💬	[1] NQO1 💬 Chemical carcinogenesis - reactive oxygen species × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1	Warfarin potassium 💬 Chemical carcinogenesis - reactive oxygen species × Name Other Names Warfarin potassium Warfarin potassium (JP18) Athrombin-K (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 148. Chemical carcinogenesis - reactive oxygen species × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
150	Chemical carcinogenesis - reactive oxygen species 💬	[1] NQO1 💬 Chemical carcinogenesis - reactive oxygen species × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1	Warfarin 💬 Chemical carcinogenesis - reactive oxygen species × Name Other Names Warfarin Warfarin (INN) Warfarine Choice (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 148. Chemical carcinogenesis - reactive oxygen species × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
151	Chemical carcinogenesis - reactive oxygen species 💬	[4] P38, P38, P38, P38 💬 Chemical carcinogenesis - reactive oxygen species × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Chemical carcinogenesis - reactive oxygen species × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 151. Chemical carcinogenesis - reactive oxygen species × Disease ID Name  8  Huntington disease;Huntington chorea;
152	Chemical carcinogenesis - receptor activation 💬	[5] ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Chemical carcinogenesis - receptor activation × Name Full Name ADRB1 adrenoceptor beta 1 CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Chemical carcinogenesis - receptor activation × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 152. Chemical carcinogenesis - receptor activation × Disease ID Name  8  Huntington disease;Huntington chorea;
153	Chemical carcinogenesis - receptor activation 💬	[1] NR1C1 💬 Chemical carcinogenesis - receptor activation × Name Full Name NR1C1	Fenofibrate 💬 Chemical carcinogenesis - receptor activation × Name Other Names Fenofibrate Fenofibrate (JP18/USP/INN) Antara (TN) Lipantil (TN) Lipofen (TN) Tricor (TN) Triglide (TN) ANTARA LIPOFEN TRICOR FENOFIBRATE	Fenofibrate	[6]  8 , 79, 93, 94, 97, 265 💬 153. Chemical carcinogenesis - receptor activation × Disease ID Name  8  Huntington disease;Huntington chorea; 79 Homozygous familial hypercholesterolemia;Familial hypercholesterolaemia; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 265 Lipodystrophy;
154	Choline metabolism in cancer 💬	[2] PDGFRA, PDGFRB 💬 Choline metabolism in cancer × Name Full Name PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 Choline metabolism in cancer × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 154. Choline metabolism in cancer × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
155	Cholinergic synapse 💬	[1] ACHE 💬 Cholinergic synapse × Name Full Name ACHE acetylcholinesterase (Yt blood group)	Latrepirdine 💬 Cholinergic synapse × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 155. Cholinergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
156	Cholinergic synapse 💬	[1] ACHE 💬 Cholinergic synapse × Name Full Name ACHE acetylcholinesterase (Yt blood group)	Latrepirdine dihydrochloride 💬 Cholinergic synapse × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 155. Cholinergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
157	Cholinergic synapse 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Cholinergic synapse × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Cholinergic synapse × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 157. Cholinergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
158	Chronic myeloid leukemia 💬	[1] ABL1 💬 Chronic myeloid leukemia × Name Full Name ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase	Nilotinib 💬 Chronic myeloid leukemia × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 158. Chronic myeloid leukemia × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
159	Circadian entrainment 💬	[2] CACNA1C, CACNA1D 💬 Circadian entrainment × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D	Bevantolol hydrochloride 💬 Circadian entrainment × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 159. Circadian entrainment × Disease ID Name  8  Huntington disease;Huntington chorea;
160	Circadian entrainment 💬	[9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Circadian entrainment × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIA3 glutamate ionotropic receptor AMPA type subunit 3 GRIA4 glutamate ionotropic receptor AMPA type subunit 4 GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Circadian entrainment × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 160. Circadian entrainment × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
161	Circadian entrainment 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Circadian entrainment × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Circadian entrainment × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 161. Circadian entrainment × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
162	Circadian entrainment 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Circadian entrainment × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Circadian entrainment × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 161. Circadian entrainment × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
163	Circadian entrainment 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Circadian entrainment × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan hydrobromide 💬 Circadian entrainment × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 163. Circadian entrainment × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
164	Circadian entrainment 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Circadian entrainment × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan 💬 Circadian entrainment × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 163. Circadian entrainment × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
165	Circadian entrainment 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Circadian entrainment × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Circadian entrainment × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 165. Circadian entrainment × Disease ID Name  8  Huntington disease;Huntington chorea;
166	Circadian entrainment 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Circadian entrainment × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Circadian entrainment × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 165. Circadian entrainment × Disease ID Name  8  Huntington disease;Huntington chorea;
167	Circadian entrainment 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Circadian entrainment × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Circadian entrainment × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 167. Circadian entrainment × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
168	Circadian entrainment 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Circadian entrainment × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Circadian entrainment × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 167. Circadian entrainment × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
169	Circadian entrainment 💬	[2] MTNR1A, MTNR1B 💬 Circadian entrainment × Name Full Name MTNR1A melatonin receptor 1A MTNR1B melatonin receptor 1B	Melatonin 💬 Circadian entrainment × Name Other Names Melatonin Melatonin (JAN) Melatonina (TN) Melatobel (TN)	Melatonin	[17]  2 ,  6 ,  8 , 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202, 265 💬 169. Circadian entrainment × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 37 Generalised pustular psoriasis;GPP;Pustular psoriasis;Herpetic impetigo; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 72 Pituitary ADH secretion disorder;Inappropriate antidiuretic hormone secretion;Syndrome of inappropriate secretion of antidiuretic hormone;Inappropriate ADH syndrome;Syndrome of inappropriate ADH;Central diabetes insipidus;Syndrome of inappropriate secretion of ADH;SIADH; 78 Hypopituitarism;Anterior pituitary hypothyroidism; 86 Pulmonary arterial hypertension;PAH; 90 Retinitis pigmentosa;Rod dystrophy;Cone-rod dystrophy;Rod-Cone Dystrophy; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 145 West syndrome;Infantile spasm;Infantile spasms;Infantile spasms syndrome;Infantile epileptic spasms;Infantile epileptic spasms syndrome; 149 Hemiconvulsion hemiplegia epilepsy syndrome;One side convulsions;Hemiplegia;Epilepsy syndrome; 202 Smith-Magenis syndrome; 265 Lipodystrophy;
170	Circadian entrainment 💬	[2] MTNR1A, MTNR1B 💬 Circadian entrainment × Name Full Name MTNR1A melatonin receptor 1A MTNR1B melatonin receptor 1B	Ramelteon 💬 Circadian entrainment × Name Other Names Ramelteon Ramelteon (JAN/USAN/INN) Rozerem (TN) ROZEREM RAMELTEON	Ramelteon	[3]  6 ,  8 , 46 💬 170. Circadian entrainment × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV;
171	Circadian rhythm 💬	[2] PRKAA, PRKAA 💬 Circadian rhythm × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Circadian rhythm × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 171. Circadian rhythm × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
172	Circadian rhythm 💬	[2] PRKAA, PRKAA 💬 Circadian rhythm × Name Full Name PRKAA PRKAA	Metformin 💬 Circadian rhythm × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 171. Circadian rhythm × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
173	Cocaine addiction 💬	[1] DRD2 💬 Cocaine addiction × Name Full Name DRD2 dopamine receptor D2	Haloperidol 💬 Cocaine addiction × Name Other Names Haloperidol Haloperidol (JP18/USP/INN) Haldol (TN)	Haloperidol	[1]  8  💬 173. Cocaine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
174	Cocaine addiction 💬	[1] DRD2 💬 Cocaine addiction × Name Full Name DRD2 dopamine receptor D2	Haloperidol decanoate 💬 Cocaine addiction × Name Other Names Haloperidol decanoate Haloperidol decanoate (JAN/USP) Halomonth (TN) HALDOL DECANOATE HALOPERIDOL DECANOATE	Haloperidol	[1]  8  💬 173. Cocaine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
175	Cocaine addiction 💬	[1] DRD2 💬 Cocaine addiction × Name Full Name DRD2 dopamine receptor D2	Haloperidol lactate 💬 Cocaine addiction × Name Other Names Haloperidol lactate Haloperidol lactate Haldol (TN)	Haloperidol	[1]  8  💬 173. Cocaine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
176	Cocaine addiction 💬	[1] DRD2 💬 Cocaine addiction × Name Full Name DRD2 dopamine receptor D2	Olanzapine 💬 Cocaine addiction × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 176. Cocaine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
177	Cocaine addiction 💬	[1] DRD2 💬 Cocaine addiction × Name Full Name DRD2 dopamine receptor D2	Olanzapine pamoate 💬 Cocaine addiction × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 176. Cocaine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
178	Cocaine addiction 💬	[1] DRD2 💬 Cocaine addiction × Name Full Name DRD2 dopamine receptor D2	Pridopidine 💬 Cocaine addiction × Name Other Names Pridopidine Pridopidine (USAN/INN)	Pridopidine	[3]  2 ,  6 ,  8  💬 178. Cocaine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
179	Cocaine addiction 💬	[1] DRD2 💬 Cocaine addiction × Name Full Name DRD2 dopamine receptor D2	Pridopidine hydrochloride 💬 Cocaine addiction × Name Other Names Pridopidine hydrochloride Pridopidine hydrochloride (USAN)	Pridopidine	[3]  2 ,  6 ,  8  💬 178. Cocaine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
180	Cocaine addiction 💬	[1] DRD2 💬 Cocaine addiction × Name Full Name DRD2 dopamine receptor D2	Risperidone 💬 Cocaine addiction × Name Other Names Risperidone Risperidone (JP18/USP/INN) Risperdal (TN) PERSERIS RISPERDAL CONSTA RISPERIDONE RYKINDO UZEDY	Risperidone	[3]  8 , 156, 187 💬 180. Cocaine addiction × Disease ID Name  8  Huntington disease;Huntington chorea; 156 Rett syndrome; 187 Kabuki syndrome;
181	Cocaine addiction 💬	[6] GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Cocaine addiction × Name Full Name GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Cocaine addiction × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 181. Cocaine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
182	Cocaine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Cocaine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Cocaine addiction × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 182. Cocaine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
183	Cocaine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Cocaine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Cocaine addiction × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 182. Cocaine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
184	Cocaine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Cocaine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan hydrobromide 💬 Cocaine addiction × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 184. Cocaine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
185	Cocaine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Cocaine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan 💬 Cocaine addiction × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 184. Cocaine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
186	Cocaine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Cocaine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Cocaine addiction × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 186. Cocaine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
187	Cocaine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Cocaine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Cocaine addiction × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 186. Cocaine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
188	Cocaine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Cocaine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Cocaine addiction × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 188. Cocaine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
189	Cocaine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Cocaine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Cocaine addiction × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 188. Cocaine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
190	Cocaine addiction 💬	[1] SLC18A1_2 💬 Cocaine addiction × Name Full Name SLC18A1_2	Deutetrabenazine 💬 Cocaine addiction × Name Other Names Deutetrabenazine Deutetrabenazine (USAN/INN) Austedo (TN) DEUTETRABENAZINE	Deutetrabenazine	[1]  8  💬 190. Cocaine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
191	Cocaine addiction 💬	[1] SLC18A1_2 💬 Cocaine addiction × Name Full Name SLC18A1_2	Tetrabenazine 💬 Cocaine addiction × Name Other Names Tetrabenazine Tetrabenazine (JAN/INN) Nitoman (TN) Xenazine (TN) XENAZINE TETRABENAZINE	Tetrabenazine	[1]  8  💬 191. Cocaine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
192	Cocaine addiction 💬	[1] SLC18A1_2 💬 Cocaine addiction × Name Full Name SLC18A1_2	Valbenazine 💬 Cocaine addiction × Name Other Names Valbenazine Valbenazine (USAN/INN)	Valbenazine	[1]  8  💬 192. Cocaine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
193	Cocaine addiction 💬	[1] SLC18A1_2 💬 Cocaine addiction × Name Full Name SLC18A1_2	Valbenazine tosylate 💬 Cocaine addiction × Name Other Names Valbenazine tosylate Valbenazine tosylate (USAN) Valbenazine tosilate (JAN) Valbenazine ditosylate Ingrezza (TN) Dysval (TN) VALBENAZINE	Valbenazine	[1]  8  💬 192. Cocaine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
194	Cocaine addiction 💬	[1] SLC6A3 💬 Cocaine addiction × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion hydrochloride 💬 Cocaine addiction × Name Other Names Bupropion hydrochloride Bupropion hydrochloride (JAN/USP) Wellbutrin (TN) Zyban (TN) FORFIVO WELLBUTRIN BUPROPION BUPROPION HCL BUPROPION HCL ER BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE SR	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 194. Cocaine addiction × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
195	Cocaine addiction 💬	[1] SLC6A3 💬 Cocaine addiction × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion 💬 Cocaine addiction × Name Other Names Bupropion Bupropion (INN)	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 194. Cocaine addiction × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
196	Cocaine addiction 💬	[1] SLC6A3 💬 Cocaine addiction × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion hydrobromide 💬 Cocaine addiction × Name Other Names Bupropion hydrobromide Bupropion hydrobromide (USAN) Aplenzin (TN) APLENZIN	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 194. Cocaine addiction × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
197	Coronavirus disease - COVID-19 💬	[4] P38, P38, P38, P38 💬 Coronavirus disease - COVID-19 × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Coronavirus disease - COVID-19 × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 197. Coronavirus disease - COVID-19 × Disease ID Name  8  Huntington disease;Huntington chorea;
198	Cortisol synthesis and secretion 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Cortisol synthesis and secretion × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Cortisol synthesis and secretion × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 198. Cortisol synthesis and secretion × Disease ID Name  8  Huntington disease;Huntington chorea;
199	Cushing syndrome 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Cushing syndrome × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Cushing syndrome × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 199. Cushing syndrome × Disease ID Name  8  Huntington disease;Huntington chorea;
200	Cytoskeleton in muscle cells 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Cytoskeleton in muscle cells × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Cytoskeleton in muscle cells × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 200. Cytoskeleton in muscle cells × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
201	Diabetic cardiomyopathy 💬	[1] NR1C1 💬 Diabetic cardiomyopathy × Name Full Name NR1C1	Fenofibrate 💬 Diabetic cardiomyopathy × Name Other Names Fenofibrate Fenofibrate (JP18/USP/INN) Antara (TN) Lipantil (TN) Lipofen (TN) Tricor (TN) Triglide (TN) ANTARA LIPOFEN TRICOR FENOFIBRATE	Fenofibrate	[6]  8 , 79, 93, 94, 97, 265 💬 201. Diabetic cardiomyopathy × Disease ID Name  8  Huntington disease;Huntington chorea; 79 Homozygous familial hypercholesterolemia;Familial hypercholesterolaemia; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 265 Lipodystrophy;
202	Diabetic cardiomyopathy 💬	[4] P38, P38, P38, P38 💬 Diabetic cardiomyopathy × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Diabetic cardiomyopathy × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 202. Diabetic cardiomyopathy × Disease ID Name  8  Huntington disease;Huntington chorea;
203	Dilated cardiomyopathy 💬	[5] ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Dilated cardiomyopathy × Name Full Name ADRB1 adrenoceptor beta 1 CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Dilated cardiomyopathy × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 203. Dilated cardiomyopathy × Disease ID Name  8  Huntington disease;Huntington chorea;
204	Dopaminergic synapse 💬	[2] CACNA1C, CACNA1D 💬 Dopaminergic synapse × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D	Bevantolol hydrochloride 💬 Dopaminergic synapse × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 204. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
205	Dopaminergic synapse 💬	[1] DRD2 💬 Dopaminergic synapse × Name Full Name DRD2 dopamine receptor D2	Haloperidol 💬 Dopaminergic synapse × Name Other Names Haloperidol Haloperidol (JP18/USP/INN) Haldol (TN)	Haloperidol	[1]  8  💬 205. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
206	Dopaminergic synapse 💬	[1] DRD2 💬 Dopaminergic synapse × Name Full Name DRD2 dopamine receptor D2	Haloperidol decanoate 💬 Dopaminergic synapse × Name Other Names Haloperidol decanoate Haloperidol decanoate (JAN/USP) Halomonth (TN) HALDOL DECANOATE HALOPERIDOL DECANOATE	Haloperidol	[1]  8  💬 205. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
207	Dopaminergic synapse 💬	[1] DRD2 💬 Dopaminergic synapse × Name Full Name DRD2 dopamine receptor D2	Haloperidol lactate 💬 Dopaminergic synapse × Name Other Names Haloperidol lactate Haloperidol lactate Haldol (TN)	Haloperidol	[1]  8  💬 205. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
208	Dopaminergic synapse 💬	[1] DRD2 💬 Dopaminergic synapse × Name Full Name DRD2 dopamine receptor D2	Pridopidine 💬 Dopaminergic synapse × Name Other Names Pridopidine Pridopidine (USAN/INN)	Pridopidine	[3]  2 ,  6 ,  8  💬 208. Dopaminergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
209	Dopaminergic synapse 💬	[1] DRD2 💬 Dopaminergic synapse × Name Full Name DRD2 dopamine receptor D2	Pridopidine hydrochloride 💬 Dopaminergic synapse × Name Other Names Pridopidine hydrochloride Pridopidine hydrochloride (USAN)	Pridopidine	[3]  2 ,  6 ,  8  💬 208. Dopaminergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
210	Dopaminergic synapse 💬	[1] DRD2 💬 Dopaminergic synapse × Name Full Name DRD2 dopamine receptor D2	Risperidone 💬 Dopaminergic synapse × Name Other Names Risperidone Risperidone (JP18/USP/INN) Risperdal (TN) PERSERIS RISPERDAL CONSTA RISPERIDONE RYKINDO UZEDY	Risperidone	[3]  8 , 156, 187 💬 210. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea; 156 Rett syndrome; 187 Kabuki syndrome;
211	Dopaminergic synapse 💬	[3] DRD2, DRD3, DRD4 💬 Dopaminergic synapse × Name Full Name DRD2 dopamine receptor D2 DRD3 dopamine receptor D3 DRD4 dopamine receptor D4	Olanzapine 💬 Dopaminergic synapse × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 211. Dopaminergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
212	Dopaminergic synapse 💬	[3] DRD2, DRD3, DRD4 💬 Dopaminergic synapse × Name Full Name DRD2 dopamine receptor D2 DRD3 dopamine receptor D3 DRD4 dopamine receptor D4	Olanzapine pamoate 💬 Dopaminergic synapse × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 211. Dopaminergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
213	Dopaminergic synapse 💬	[6] GRIA1, GRIA2, GRIA3, GRIA4, GRIN2A, GRIN2B 💬 Dopaminergic synapse × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIA3 glutamate ionotropic receptor AMPA type subunit 3 GRIA4 glutamate ionotropic receptor AMPA type subunit 4 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Riluzole 💬 Dopaminergic synapse × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 213. Dopaminergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
214	Dopaminergic synapse 💬	[2] GRIN2A, GRIN2B 💬 Dopaminergic synapse × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Amantadine hydrochloride 💬 Dopaminergic synapse × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 214. Dopaminergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
215	Dopaminergic synapse 💬	[2] GRIN2A, GRIN2B 💬 Dopaminergic synapse × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Amantadine 💬 Dopaminergic synapse × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 214. Dopaminergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
216	Dopaminergic synapse 💬	[2] GRIN2A, GRIN2B 💬 Dopaminergic synapse × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Dextromethorphan hydrobromide 💬 Dopaminergic synapse × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 216. Dopaminergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
217	Dopaminergic synapse 💬	[2] GRIN2A, GRIN2B 💬 Dopaminergic synapse × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Dextromethorphan 💬 Dopaminergic synapse × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 216. Dopaminergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
218	Dopaminergic synapse 💬	[2] GRIN2A, GRIN2B 💬 Dopaminergic synapse × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Latrepirdine 💬 Dopaminergic synapse × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 218. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
219	Dopaminergic synapse 💬	[2] GRIN2A, GRIN2B 💬 Dopaminergic synapse × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Latrepirdine dihydrochloride 💬 Dopaminergic synapse × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 218. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
220	Dopaminergic synapse 💬	[2] GRIN2A, GRIN2B 💬 Dopaminergic synapse × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Memantine hydrochloride 💬 Dopaminergic synapse × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 220. Dopaminergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
221	Dopaminergic synapse 💬	[2] GRIN2A, GRIN2B 💬 Dopaminergic synapse × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Memantine 💬 Dopaminergic synapse × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 220. Dopaminergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
222	Dopaminergic synapse 💬	[4] P38, P38, P38, P38 💬 Dopaminergic synapse × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Dopaminergic synapse × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 222. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
223	Dopaminergic synapse 💬	[1] SCN1A 💬 Dopaminergic synapse × Name Full Name SCN1A sodium voltage-gated channel alpha subunit 1	Quinidine gluconate 💬 Dopaminergic synapse × Name Other Names Quinidine gluconate Quinidine gluconate (USP) Quinaglute (TN)	Quinidine	[2]  8 , 13 💬 223. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
224	Dopaminergic synapse 💬	[1] SCN1A 💬 Dopaminergic synapse × Name Full Name SCN1A sodium voltage-gated channel alpha subunit 1	Quinidine polygalacturonate 💬 Dopaminergic synapse × Name Other Names Quinidine polygalacturonate Quinidine polygalacturonate Cardioquin (TN)	Quinidine	[2]  8 , 13 💬 223. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
225	Dopaminergic synapse 💬	[1] SCN1A 💬 Dopaminergic synapse × Name Full Name SCN1A sodium voltage-gated channel alpha subunit 1	Quinidine sulfate 💬 Dopaminergic synapse × Name Other Names Quinidine sulfate Quinidine sulfate (USP) Quinidine sulfate hydrate (JP18) Quinidex (TN)	Quinidine	[2]  8 , 13 💬 223. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
226	Dopaminergic synapse 💬	[1] SCN1A 💬 Dopaminergic synapse × Name Full Name SCN1A sodium voltage-gated channel alpha subunit 1	Quinidine 💬 Dopaminergic synapse × Name Other Names Quinidine Quinidine (BAN) Kinidin (TN)	Quinidine	[2]  8 , 13 💬 223. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
227	Dopaminergic synapse 💬	[1] SLC18A1_2 💬 Dopaminergic synapse × Name Full Name SLC18A1_2	Deutetrabenazine 💬 Dopaminergic synapse × Name Other Names Deutetrabenazine Deutetrabenazine (USAN/INN) Austedo (TN) DEUTETRABENAZINE	Deutetrabenazine	[1]  8  💬 227. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
228	Dopaminergic synapse 💬	[1] SLC18A1_2 💬 Dopaminergic synapse × Name Full Name SLC18A1_2	Tetrabenazine 💬 Dopaminergic synapse × Name Other Names Tetrabenazine Tetrabenazine (JAN/INN) Nitoman (TN) Xenazine (TN) XENAZINE TETRABENAZINE	Tetrabenazine	[1]  8  💬 228. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
229	Dopaminergic synapse 💬	[1] SLC18A1_2 💬 Dopaminergic synapse × Name Full Name SLC18A1_2	Valbenazine 💬 Dopaminergic synapse × Name Other Names Valbenazine Valbenazine (USAN/INN)	Valbenazine	[1]  8  💬 229. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
230	Dopaminergic synapse 💬	[1] SLC18A1_2 💬 Dopaminergic synapse × Name Full Name SLC18A1_2	Valbenazine tosylate 💬 Dopaminergic synapse × Name Other Names Valbenazine tosylate Valbenazine tosylate (USAN) Valbenazine tosilate (JAN) Valbenazine ditosylate Ingrezza (TN) Dysval (TN) VALBENAZINE	Valbenazine	[1]  8  💬 229. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
231	Dopaminergic synapse 💬	[1] SLC6A3 💬 Dopaminergic synapse × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion hydrochloride 💬 Dopaminergic synapse × Name Other Names Bupropion hydrochloride Bupropion hydrochloride (JAN/USP) Wellbutrin (TN) Zyban (TN) FORFIVO WELLBUTRIN BUPROPION BUPROPION HCL BUPROPION HCL ER BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE SR	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 231. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
232	Dopaminergic synapse 💬	[1] SLC6A3 💬 Dopaminergic synapse × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion 💬 Dopaminergic synapse × Name Other Names Bupropion Bupropion (INN)	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 231. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
233	Dopaminergic synapse 💬	[1] SLC6A3 💬 Dopaminergic synapse × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion hydrobromide 💬 Dopaminergic synapse × Name Other Names Bupropion hydrobromide Bupropion hydrobromide (USAN) Aplenzin (TN) APLENZIN	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 231. Dopaminergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
234	Efferocytosis 💬	[4] P38, P38, P38, P38 💬 Efferocytosis × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Efferocytosis × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 234. Efferocytosis × Disease ID Name  8  Huntington disease;Huntington chorea;
235	Endocrine and other factor-regulated calcium reabsorption 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Endocrine and other factor-regulated calcium reabsorption × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Endocrine and other factor-regulated calcium reabsorption × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 235. Endocrine and other factor-regulated calcium reabsorption × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
236	Endocytosis 💬	[1] PDGFRA 💬 Endocytosis × Name Full Name PDGFRA platelet derived growth factor receptor alpha	Nilotinib 💬 Endocytosis × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 236. Endocytosis × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
237	Epithelial cell signaling in Helicobacter pylori infection 💬	[4] P38, P38, P38, P38 💬 Epithelial cell signaling in Helicobacter pylori infection × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Epithelial cell signaling in Helicobacter pylori infection × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 237. Epithelial cell signaling in Helicobacter pylori infection × Disease ID Name  8  Huntington disease;Huntington chorea;
238	Epstein-Barr virus infection 💬	[4] P38, P38, P38, P38 💬 Epstein-Barr virus infection × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Epstein-Barr virus infection × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 238. Epstein-Barr virus infection × Disease ID Name  8  Huntington disease;Huntington chorea;
239	ErbB signaling pathway 💬	[1] ABL1 💬 ErbB signaling pathway × Name Full Name ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase	Nilotinib 💬 ErbB signaling pathway × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 239. ErbB signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
240	Fc epsilon RI signaling pathway 💬	[4] P38, P38, P38, P38 💬 Fc epsilon RI signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Fc epsilon RI signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 240. Fc epsilon RI signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
241	Fluid shear stress and atherosclerosis 💬	[1] NQO1 💬 Fluid shear stress and atherosclerosis × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1	Warfarin sodium 💬 Fluid shear stress and atherosclerosis × Name Other Names Warfarin sodium Warfarin sodium (USP) Coumadin (TN) Jantoven (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 241. Fluid shear stress and atherosclerosis × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
242	Fluid shear stress and atherosclerosis 💬	[1] NQO1 💬 Fluid shear stress and atherosclerosis × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1	Warfarin potassium 💬 Fluid shear stress and atherosclerosis × Name Other Names Warfarin potassium Warfarin potassium (JP18) Athrombin-K (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 241. Fluid shear stress and atherosclerosis × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
243	Fluid shear stress and atherosclerosis 💬	[1] NQO1 💬 Fluid shear stress and atherosclerosis × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1	Warfarin 💬 Fluid shear stress and atherosclerosis × Name Other Names Warfarin Warfarin (INN) Warfarine Choice (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 241. Fluid shear stress and atherosclerosis × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
244	Fluid shear stress and atherosclerosis 💬	[4] P38, P38, P38, P38 💬 Fluid shear stress and atherosclerosis × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Fluid shear stress and atherosclerosis × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 244. Fluid shear stress and atherosclerosis × Disease ID Name  8  Huntington disease;Huntington chorea;
245	Fluid shear stress and atherosclerosis 💬	[2] PRKAA, PRKAA 💬 Fluid shear stress and atherosclerosis × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Fluid shear stress and atherosclerosis × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 245. Fluid shear stress and atherosclerosis × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
246	Fluid shear stress and atherosclerosis 💬	[2] PRKAA, PRKAA 💬 Fluid shear stress and atherosclerosis × Name Full Name PRKAA PRKAA	Metformin 💬 Fluid shear stress and atherosclerosis × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 245. Fluid shear stress and atherosclerosis × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
247	Focal adhesion 💬	[2] PDGFRA, PDGFRB 💬 Focal adhesion × Name Full Name PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 Focal adhesion × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 247. Focal adhesion × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
248	FoxO signaling pathway 💬	[4] P38, P38, P38, P38 💬 FoxO signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 FoxO signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 248. FoxO signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
249	FoxO signaling pathway 💬	[2] PRKAA, PRKAA 💬 FoxO signaling pathway × Name Full Name PRKAA PRKAA	Metformin 💬 FoxO signaling pathway × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 249. FoxO signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
250	FoxO signaling pathway 💬	[2] PRKAA, PRKAA 💬 FoxO signaling pathway × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 FoxO signaling pathway × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 249. FoxO signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
251	GABAergic synapse 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 GABAergic synapse × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 GABAergic synapse × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 251. GABAergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
252	GABAergic synapse 💬	[16] GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 GABAergic synapse × Name Full Name GABRA GABRA GABRA GABRA GABRA GABRA GABRB GABRB GABRB GABRD gamma-aminobutyric acid type A receptor subunit delta GABRE gamma-aminobutyric acid type A receptor subunit epsilon GABRG GABRG GABRG GABRP gamma-aminobutyric acid type A receptor subunit pi GABRQ gamma-aminobutyric acid type A receptor subunit theta	Alprazolam 💬 GABAergic synapse × Name Other Names Alprazolam Alprazolam (JP18/USP/INN) Xanax (TN) XANAX ALPRAZOLAM ALPRAZOLAM C-IV	Alprazolam	[2]  8 , 75 💬 252. GABAergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea; 75 Cushing disease;Cushing syndrome;
253	Gap junction 💬	[1] ADRB1 💬 Gap junction × Name Full Name ADRB1 adrenoceptor beta 1	Bevantolol hydrochloride 💬 Gap junction × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 253. Gap junction × Disease ID Name  8  Huntington disease;Huntington chorea;
254	Gap junction 💬	[1] DRD2 💬 Gap junction × Name Full Name DRD2 dopamine receptor D2	Haloperidol 💬 Gap junction × Name Other Names Haloperidol Haloperidol (JP18/USP/INN) Haldol (TN)	Haloperidol	[1]  8  💬 254. Gap junction × Disease ID Name  8  Huntington disease;Huntington chorea;
255	Gap junction 💬	[1] DRD2 💬 Gap junction × Name Full Name DRD2 dopamine receptor D2	Haloperidol decanoate 💬 Gap junction × Name Other Names Haloperidol decanoate Haloperidol decanoate (JAN/USP) Halomonth (TN) HALDOL DECANOATE HALOPERIDOL DECANOATE	Haloperidol	[1]  8  💬 254. Gap junction × Disease ID Name  8  Huntington disease;Huntington chorea;
256	Gap junction 💬	[1] DRD2 💬 Gap junction × Name Full Name DRD2 dopamine receptor D2	Haloperidol lactate 💬 Gap junction × Name Other Names Haloperidol lactate Haloperidol lactate Haldol (TN)	Haloperidol	[1]  8  💬 254. Gap junction × Disease ID Name  8  Huntington disease;Huntington chorea;
257	Gap junction 💬	[1] DRD2 💬 Gap junction × Name Full Name DRD2 dopamine receptor D2	Pridopidine 💬 Gap junction × Name Other Names Pridopidine Pridopidine (USAN/INN)	Pridopidine	[3]  2 ,  6 ,  8  💬 257. Gap junction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
258	Gap junction 💬	[1] DRD2 💬 Gap junction × Name Full Name DRD2 dopamine receptor D2	Pridopidine hydrochloride 💬 Gap junction × Name Other Names Pridopidine hydrochloride Pridopidine hydrochloride (USAN)	Pridopidine	[3]  2 ,  6 ,  8  💬 257. Gap junction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
259	Gap junction 💬	[2] DRD2, HTR2 💬 Gap junction × Name Full Name DRD2 dopamine receptor D2 HTR2	Risperidone 💬 Gap junction × Name Other Names Risperidone Risperidone (JP18/USP/INN) Risperdal (TN) PERSERIS RISPERDAL CONSTA RISPERIDONE RYKINDO UZEDY	Risperidone	[3]  8 , 156, 187 💬 259. Gap junction × Disease ID Name  8  Huntington disease;Huntington chorea; 156 Rett syndrome; 187 Kabuki syndrome;
260	Gap junction 💬	[4] DRD2, HTR2, HTR2, HTR2 💬 Gap junction × Name Full Name DRD2 dopamine receptor D2 HTR2 HTR2 HTR2	Olanzapine pamoate 💬 Gap junction × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 260. Gap junction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
261	Gap junction 💬	[4] DRD2, HTR2, HTR2, HTR2 💬 Gap junction × Name Full Name DRD2 dopamine receptor D2 HTR2 HTR2 HTR2	Olanzapine 💬 Gap junction × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 261. Gap junction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
262	Gap junction 💬	[2] PDGFRA, PDGFRB 💬 Gap junction × Name Full Name PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 Gap junction × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 262. Gap junction × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
263	Gastric acid secretion 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Gastric acid secretion × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Gastric acid secretion × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 263. Gastric acid secretion × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
264	Glioma 💬	[2] PDGFRA, PDGFRB 💬 Glioma × Name Full Name PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 Glioma × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 264. Glioma × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
265	Glucagon signaling pathway 💬	[1] NR1C1 💬 Glucagon signaling pathway × Name Full Name NR1C1	Fenofibrate 💬 Glucagon signaling pathway × Name Other Names Fenofibrate Fenofibrate (JP18/USP/INN) Antara (TN) Lipantil (TN) Lipofen (TN) Tricor (TN) Triglide (TN) ANTARA LIPOFEN TRICOR FENOFIBRATE	Fenofibrate	[6]  8 , 79, 93, 94, 97, 265 💬 265. Glucagon signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea; 79 Homozygous familial hypercholesterolemia;Familial hypercholesterolaemia; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 265 Lipodystrophy;
266	Glucagon signaling pathway 💬	[2] PRKAA, PRKAA 💬 Glucagon signaling pathway × Name Full Name PRKAA PRKAA	Metformin 💬 Glucagon signaling pathway × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 266. Glucagon signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
267	Glucagon signaling pathway 💬	[2] PRKAA, PRKAA 💬 Glucagon signaling pathway × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Glucagon signaling pathway × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 266. Glucagon signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
268	Glutamatergic synapse 💬	[2] CACNA1C, CACNA1D 💬 Glutamatergic synapse × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D	Bevantolol hydrochloride 💬 Glutamatergic synapse × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 268. Glutamatergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
269	Glutamatergic synapse 💬	[14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Glutamatergic synapse × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIA3 glutamate ionotropic receptor AMPA type subunit 3 GRIA4 glutamate ionotropic receptor AMPA type subunit 4 GRIK1 glutamate ionotropic receptor kainate type subunit 1 GRIK2 glutamate ionotropic receptor kainate type subunit 2 GRIK3 glutamate ionotropic receptor kainate type subunit 3 GRIK4 glutamate ionotropic receptor kainate type subunit 4 GRIK5 glutamate ionotropic receptor kainate type subunit 5 GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Glutamatergic synapse × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 269. Glutamatergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
270	Glutamatergic synapse 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Glutamatergic synapse × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Glutamatergic synapse × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 270. Glutamatergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
271	Glutamatergic synapse 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Glutamatergic synapse × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Glutamatergic synapse × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 270. Glutamatergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
272	Glutamatergic synapse 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Glutamatergic synapse × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan hydrobromide 💬 Glutamatergic synapse × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 272. Glutamatergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
273	Glutamatergic synapse 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Glutamatergic synapse × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan 💬 Glutamatergic synapse × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 272. Glutamatergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
274	Glutamatergic synapse 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Glutamatergic synapse × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Glutamatergic synapse × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 274. Glutamatergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
275	Glutamatergic synapse 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Glutamatergic synapse × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Glutamatergic synapse × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 274. Glutamatergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
276	Glutamatergic synapse 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Glutamatergic synapse × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Glutamatergic synapse × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 276. Glutamatergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
277	Glutamatergic synapse 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Glutamatergic synapse × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Glutamatergic synapse × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 276. Glutamatergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
278	Glycerophospholipid metabolism 💬	[1] ACHE 💬 Glycerophospholipid metabolism × Name Full Name ACHE acetylcholinesterase (Yt blood group)	Latrepirdine 💬 Glycerophospholipid metabolism × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 278. Glycerophospholipid metabolism × Disease ID Name  8  Huntington disease;Huntington chorea;
279	Glycerophospholipid metabolism 💬	[1] ACHE 💬 Glycerophospholipid metabolism × Name Full Name ACHE acetylcholinesterase (Yt blood group)	Latrepirdine dihydrochloride 💬 Glycerophospholipid metabolism × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 278. Glycerophospholipid metabolism × Disease ID Name  8  Huntington disease;Huntington chorea;
280	GnRH secretion 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 GnRH secretion × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 GnRH secretion × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 280. GnRH secretion × Disease ID Name  8  Huntington disease;Huntington chorea;
281	GnRH signaling pathway 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 GnRH signaling pathway × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 GnRH signaling pathway × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 281. GnRH signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
282	GnRH signaling pathway 💬	[4] P38, P38, P38, P38 💬 GnRH signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 GnRH signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 282. GnRH signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
283	Growth hormone synthesis, secretion and action 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Growth hormone synthesis, secretion and action × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Growth hormone synthesis, secretion and action × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 283. Growth hormone synthesis, secretion and action × Disease ID Name  8  Huntington disease;Huntington chorea;
284	Growth hormone synthesis, secretion and action 💬	[4] P38, P38, P38, P38 💬 Growth hormone synthesis, secretion and action × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Growth hormone synthesis, secretion and action × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 284. Growth hormone synthesis, secretion and action × Disease ID Name  8  Huntington disease;Huntington chorea;
285	Hematopoietic cell lineage 💬	[1] KIT 💬 Hematopoietic cell lineage × Name Full Name KIT KIT proto-oncogene, receptor tyrosine kinase	Nilotinib 💬 Hematopoietic cell lineage × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 285. Hematopoietic cell lineage × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
286	Hepatitis B 💬	[4] P38, P38, P38, P38 💬 Hepatitis B × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Hepatitis B × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 286. Hepatitis B × Disease ID Name  8  Huntington disease;Huntington chorea;
287	Hepatitis C 💬	[1] NR1C1 💬 Hepatitis C × Name Full Name NR1C1	Fenofibrate 💬 Hepatitis C × Name Other Names Fenofibrate Fenofibrate (JP18/USP/INN) Antara (TN) Lipantil (TN) Lipofen (TN) Tricor (TN) Triglide (TN) ANTARA LIPOFEN TRICOR FENOFIBRATE	Fenofibrate	[6]  8 , 79, 93, 94, 97, 265 💬 287. Hepatitis C × Disease ID Name  8  Huntington disease;Huntington chorea; 79 Homozygous familial hypercholesterolemia;Familial hypercholesterolaemia; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 265 Lipodystrophy;
288	Hepatocellular carcinoma 💬	[1] NQO1 💬 Hepatocellular carcinoma × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1	Warfarin sodium 💬 Hepatocellular carcinoma × Name Other Names Warfarin sodium Warfarin sodium (USP) Coumadin (TN) Jantoven (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 288. Hepatocellular carcinoma × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
289	Hepatocellular carcinoma 💬	[1] NQO1 💬 Hepatocellular carcinoma × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1	Warfarin potassium 💬 Hepatocellular carcinoma × Name Other Names Warfarin potassium Warfarin potassium (JP18) Athrombin-K (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 288. Hepatocellular carcinoma × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
290	Hepatocellular carcinoma 💬	[1] NQO1 💬 Hepatocellular carcinoma × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1	Warfarin 💬 Hepatocellular carcinoma × Name Other Names Warfarin Warfarin (INN) Warfarine Choice (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 288. Hepatocellular carcinoma × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
291	Hormone signaling 💬	[4] ADRA1A, ADRA1B, ADRA1D, ADRB1 💬 Hormone signaling × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1	Bevantolol hydrochloride 💬 Hormone signaling × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 291. Hormone signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
292	Hormone signaling 💬	[6] ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4 💬 Hormone signaling × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D DRD2 dopamine receptor D2 DRD3 dopamine receptor D3 DRD4 dopamine receptor D4	Olanzapine 💬 Hormone signaling × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 292. Hormone signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
293	Hormone signaling 💬	[6] ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4 💬 Hormone signaling × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D DRD2 dopamine receptor D2 DRD3 dopamine receptor D3 DRD4 dopamine receptor D4	Olanzapine pamoate 💬 Hormone signaling × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 292. Hormone signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
294	Hormone signaling 💬	[3] ADRA2A, ADRA2B, ADRA2C 💬 Hormone signaling × Name Full Name ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C	Rilmenidine 💬 Hormone signaling × Name Other Names Rilmenidine Rilmenidine (INN) Hyperium (TN)	Rilmenidine	[1]  8  💬 294. Hormone signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
295	Hormone signaling 💬	[1] DRD2 💬 Hormone signaling × Name Full Name DRD2 dopamine receptor D2	Haloperidol 💬 Hormone signaling × Name Other Names Haloperidol Haloperidol (JP18/USP/INN) Haldol (TN)	Haloperidol	[1]  8  💬 295. Hormone signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
296	Hormone signaling 💬	[1] DRD2 💬 Hormone signaling × Name Full Name DRD2 dopamine receptor D2	Haloperidol decanoate 💬 Hormone signaling × Name Other Names Haloperidol decanoate Haloperidol decanoate (JAN/USP) Halomonth (TN) HALDOL DECANOATE HALOPERIDOL DECANOATE	Haloperidol	[1]  8  💬 295. Hormone signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
297	Hormone signaling 💬	[1] DRD2 💬 Hormone signaling × Name Full Name DRD2 dopamine receptor D2	Haloperidol lactate 💬 Hormone signaling × Name Other Names Haloperidol lactate Haloperidol lactate Haldol (TN)	Haloperidol	[1]  8  💬 295. Hormone signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
298	Hormone signaling 💬	[1] DRD2 💬 Hormone signaling × Name Full Name DRD2 dopamine receptor D2	Pridopidine 💬 Hormone signaling × Name Other Names Pridopidine Pridopidine (USAN/INN)	Pridopidine	[3]  2 ,  6 ,  8  💬 298. Hormone signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
299	Hormone signaling 💬	[1] DRD2 💬 Hormone signaling × Name Full Name DRD2 dopamine receptor D2	Pridopidine hydrochloride 💬 Hormone signaling × Name Other Names Pridopidine hydrochloride Pridopidine hydrochloride (USAN)	Pridopidine	[3]  2 ,  6 ,  8  💬 298. Hormone signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
300	Hormone signaling 💬	[1] DRD2 💬 Hormone signaling × Name Full Name DRD2 dopamine receptor D2	Risperidone 💬 Hormone signaling × Name Other Names Risperidone Risperidone (JP18/USP/INN) Risperdal (TN) PERSERIS RISPERDAL CONSTA RISPERIDONE RYKINDO UZEDY	Risperidone	[3]  8 , 156, 187 💬 300. Hormone signaling × Disease ID Name  8  Huntington disease;Huntington chorea; 156 Rett syndrome; 187 Kabuki syndrome;
301	Human cytomegalovirus infection 💬	[4] P38, P38, P38, P38 💬 Human cytomegalovirus infection × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Human cytomegalovirus infection × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 301. Human cytomegalovirus infection × Disease ID Name  8  Huntington disease;Huntington chorea;
302	Human cytomegalovirus infection 💬	[1] PDGFRA 💬 Human cytomegalovirus infection × Name Full Name PDGFRA platelet derived growth factor receptor alpha	Nilotinib 💬 Human cytomegalovirus infection × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 302. Human cytomegalovirus infection × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
303	Human immunodeficiency virus 1 infection 💬	[4] P38, P38, P38, P38 💬 Human immunodeficiency virus 1 infection × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Human immunodeficiency virus 1 infection × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 303. Human immunodeficiency virus 1 infection × Disease ID Name  8  Huntington disease;Huntington chorea;
304	Human papillomavirus infection 💬	[1] PDGFRB 💬 Human papillomavirus infection × Name Full Name PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 Human papillomavirus infection × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 304. Human papillomavirus infection × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
305	Huntington disease 💬	[6] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2B 💬 Huntington disease × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIA3 glutamate ionotropic receptor AMPA type subunit 3 GRIA4 glutamate ionotropic receptor AMPA type subunit 4 GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Riluzole 💬 Huntington disease × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 305. Huntington disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
306	Huntington disease 💬	[2] GRIN1, GRIN2B 💬 Huntington disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Amantadine hydrochloride 💬 Huntington disease × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 306. Huntington disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
307	Huntington disease 💬	[2] GRIN1, GRIN2B 💬 Huntington disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Amantadine 💬 Huntington disease × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 306. Huntington disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
308	Huntington disease 💬	[2] GRIN1, GRIN2B 💬 Huntington disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Dextromethorphan hydrobromide 💬 Huntington disease × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 308. Huntington disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
309	Huntington disease 💬	[2] GRIN1, GRIN2B 💬 Huntington disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Dextromethorphan 💬 Huntington disease × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 308. Huntington disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
310	Huntington disease 💬	[2] GRIN1, GRIN2B 💬 Huntington disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Latrepirdine 💬 Huntington disease × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 310. Huntington disease × Disease ID Name  8  Huntington disease;Huntington chorea;
311	Huntington disease 💬	[2] GRIN1, GRIN2B 💬 Huntington disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Latrepirdine dihydrochloride 💬 Huntington disease × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 310. Huntington disease × Disease ID Name  8  Huntington disease;Huntington chorea;
312	Huntington disease 💬	[2] GRIN1, GRIN2B 💬 Huntington disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Memantine hydrochloride 💬 Huntington disease × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 312. Huntington disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
313	Huntington disease 💬	[2] GRIN1, GRIN2B 💬 Huntington disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Memantine 💬 Huntington disease × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 312. Huntington disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
314	Huntington disease 💬	[1] HD 💬 Huntington disease × Name Full Name HD	Tominersen 💬 Huntington disease × Name Other Names Tominersen Tominersen (USAN/INN)	Tominersen	[1]  8  💬 314. Huntington disease × Disease ID Name  8  Huntington disease;Huntington chorea;
315	Hypertrophic cardiomyopathy 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Hypertrophic cardiomyopathy × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Hypertrophic cardiomyopathy × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 315. Hypertrophic cardiomyopathy × Disease ID Name  8  Huntington disease;Huntington chorea;
316	Hypertrophic cardiomyopathy 💬	[2] PRKAA, PRKAA 💬 Hypertrophic cardiomyopathy × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Hypertrophic cardiomyopathy × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 316. Hypertrophic cardiomyopathy × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
317	Hypertrophic cardiomyopathy 💬	[2] PRKAA, PRKAA 💬 Hypertrophic cardiomyopathy × Name Full Name PRKAA PRKAA	Metformin 💬 Hypertrophic cardiomyopathy × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 316. Hypertrophic cardiomyopathy × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
318	IL-17 signaling pathway 💬	[4] P38, P38, P38, P38 💬 IL-17 signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 IL-17 signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 318. IL-17 signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
319	Inflammatory mediator regulation of TRP channels 💬	[4] HRH1, HTR2, HTR2, HTR2 💬 Inflammatory mediator regulation of TRP channels × Name Full Name HRH1 histamine receptor H1 HTR2 HTR2 HTR2	Olanzapine 💬 Inflammatory mediator regulation of TRP channels × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 319. Inflammatory mediator regulation of TRP channels × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
320	Inflammatory mediator regulation of TRP channels 💬	[4] HRH1, HTR2, HTR2, HTR2 💬 Inflammatory mediator regulation of TRP channels × Name Full Name HRH1 histamine receptor H1 HTR2 HTR2 HTR2	Olanzapine pamoate 💬 Inflammatory mediator regulation of TRP channels × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 320. Inflammatory mediator regulation of TRP channels × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
321	Inflammatory mediator regulation of TRP channels 💬	[1] HTR2 💬 Inflammatory mediator regulation of TRP channels × Name Full Name HTR2	Risperidone 💬 Inflammatory mediator regulation of TRP channels × Name Other Names Risperidone Risperidone (JP18/USP/INN) Risperdal (TN) PERSERIS RISPERDAL CONSTA RISPERIDONE RYKINDO UZEDY	Risperidone	[3]  8 , 156, 187 💬 321. Inflammatory mediator regulation of TRP channels × Disease ID Name  8  Huntington disease;Huntington chorea; 156 Rett syndrome; 187 Kabuki syndrome;
322	Inflammatory mediator regulation of TRP channels 💬	[4] P38, P38, P38, P38 💬 Inflammatory mediator regulation of TRP channels × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Inflammatory mediator regulation of TRP channels × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 322. Inflammatory mediator regulation of TRP channels × Disease ID Name  8  Huntington disease;Huntington chorea;
323	Insulin resistance 💬	[1] NR1C1 💬 Insulin resistance × Name Full Name NR1C1	Fenofibrate 💬 Insulin resistance × Name Other Names Fenofibrate Fenofibrate (JP18/USP/INN) Antara (TN) Lipantil (TN) Lipofen (TN) Tricor (TN) Triglide (TN) ANTARA LIPOFEN TRICOR FENOFIBRATE	Fenofibrate	[6]  8 , 79, 93, 94, 97, 265 💬 323. Insulin resistance × Disease ID Name  8  Huntington disease;Huntington chorea; 79 Homozygous familial hypercholesterolemia;Familial hypercholesterolaemia; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 265 Lipodystrophy;
324	Insulin resistance 💬	[2] PRKAA, PRKAA 💬 Insulin resistance × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Insulin resistance × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 324. Insulin resistance × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
325	Insulin resistance 💬	[2] PRKAA, PRKAA 💬 Insulin resistance × Name Full Name PRKAA PRKAA	Metformin 💬 Insulin resistance × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 324. Insulin resistance × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
326	Insulin secretion 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Insulin secretion × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Insulin secretion × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 326. Insulin secretion × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
327	Insulin secretion 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Insulin secretion × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Insulin secretion × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 327. Insulin secretion × Disease ID Name  8  Huntington disease;Huntington chorea;
328	Insulin signaling pathway 💬	[2] PRKAA, PRKAA 💬 Insulin signaling pathway × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Insulin signaling pathway × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 328. Insulin signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
329	Insulin signaling pathway 💬	[2] PRKAA, PRKAA 💬 Insulin signaling pathway × Name Full Name PRKAA PRKAA	Metformin 💬 Insulin signaling pathway × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 328. Insulin signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
330	JAK-STAT signaling pathway 💬	[2] PDGFRA, PDGFRB 💬 JAK-STAT signaling pathway × Name Full Name PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 JAK-STAT signaling pathway × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 330. JAK-STAT signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
331	Kaposi sarcoma-associated herpesvirus infection 💬	[4] P38, P38, P38, P38 💬 Kaposi sarcoma-associated herpesvirus infection × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Kaposi sarcoma-associated herpesvirus infection × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 331. Kaposi sarcoma-associated herpesvirus infection × Disease ID Name  8  Huntington disease;Huntington chorea;
332	Leishmaniasis 💬	[4] P38, P38, P38, P38 💬 Leishmaniasis × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Leishmaniasis × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 332. Leishmaniasis × Disease ID Name  8  Huntington disease;Huntington chorea;
333	Leukocyte transendothelial migration 💬	[4] P38, P38, P38, P38 💬 Leukocyte transendothelial migration × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Leukocyte transendothelial migration × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 333. Leukocyte transendothelial migration × Disease ID Name  8  Huntington disease;Huntington chorea;
334	Lipid and atherosclerosis 💬	[4] P38, P38, P38, P38 💬 Lipid and atherosclerosis × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Lipid and atherosclerosis × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 334. Lipid and atherosclerosis × Disease ID Name  8  Huntington disease;Huntington chorea;
335	Long-term depression 💬	[3] GRIA1, GRIA2, GRIA3 💬 Long-term depression × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIA3 glutamate ionotropic receptor AMPA type subunit 3	Riluzole 💬 Long-term depression × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 335. Long-term depression × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
336	Long-term potentiation 💬	[1] CACNA1C 💬 Long-term potentiation × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C	Bevantolol hydrochloride 💬 Long-term potentiation × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 336. Long-term potentiation × Disease ID Name  8  Huntington disease;Huntington chorea;
337	Long-term potentiation 💬	[7] GRIA1, GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Long-term potentiation × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Long-term potentiation × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 337. Long-term potentiation × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
338	Long-term potentiation 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Long-term potentiation × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Long-term potentiation × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 338. Long-term potentiation × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
339	Long-term potentiation 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Long-term potentiation × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Long-term potentiation × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 338. Long-term potentiation × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
340	Long-term potentiation 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Long-term potentiation × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan hydrobromide 💬 Long-term potentiation × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 340. Long-term potentiation × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
341	Long-term potentiation 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Long-term potentiation × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan 💬 Long-term potentiation × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 340. Long-term potentiation × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
342	Long-term potentiation 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Long-term potentiation × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Long-term potentiation × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 342. Long-term potentiation × Disease ID Name  8  Huntington disease;Huntington chorea;
343	Long-term potentiation 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Long-term potentiation × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Long-term potentiation × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 342. Long-term potentiation × Disease ID Name  8  Huntington disease;Huntington chorea;
344	Long-term potentiation 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Long-term potentiation × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Long-term potentiation × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 344. Long-term potentiation × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
345	Long-term potentiation 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Long-term potentiation × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Long-term potentiation × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 344. Long-term potentiation × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
346	Longevity regulating pathway 💬	[2] PRKAA, PRKAA 💬 Longevity regulating pathway × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Longevity regulating pathway × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 346. Longevity regulating pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
347	Longevity regulating pathway 💬	[2] PRKAA, PRKAA 💬 Longevity regulating pathway × Name Full Name PRKAA PRKAA	Metformin 💬 Longevity regulating pathway × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 346. Longevity regulating pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
348	Longevity regulating pathway - multiple species 💬	[2] PRKAA, PRKAA 💬 Longevity regulating pathway - multiple species × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Longevity regulating pathway - multiple species × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 348. Longevity regulating pathway - multiple species × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
349	Longevity regulating pathway - multiple species 💬	[2] PRKAA, PRKAA 💬 Longevity regulating pathway - multiple species × Name Full Name PRKAA PRKAA	Metformin 💬 Longevity regulating pathway - multiple species × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 348. Longevity regulating pathway - multiple species × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
350	MAPK signaling pathway 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 MAPK signaling pathway × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 MAPK signaling pathway × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 350. MAPK signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
351	MAPK signaling pathway 💬	[3] KIT, PDGFRA, PDGFRB 💬 MAPK signaling pathway × Name Full Name KIT KIT proto-oncogene, receptor tyrosine kinase PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 MAPK signaling pathway × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 351. MAPK signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
352	MAPK signaling pathway 💬	[4] P38, P38, P38, P38 💬 MAPK signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 MAPK signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 352. MAPK signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
353	Melanogenesis 💬	[1] KIT 💬 Melanogenesis × Name Full Name KIT KIT proto-oncogene, receptor tyrosine kinase	Nilotinib 💬 Melanogenesis × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 353. Melanogenesis × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
354	Melanoma 💬	[2] PDGFRA, PDGFRB 💬 Melanoma × Name Full Name PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 Melanoma × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 354. Melanoma × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
355	MicroRNAs in cancer 💬	[3] ABL1, PDGFRA, PDGFRB 💬 MicroRNAs in cancer × Name Full Name ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 MicroRNAs in cancer × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 355. MicroRNAs in cancer × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
356	Mineral absorption 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Mineral absorption × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Mineral absorption × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 356. Mineral absorption × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
357	Morphine addiction 💬	[16] GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Morphine addiction × Name Full Name GABRA GABRA GABRA GABRA GABRA GABRA GABRB GABRB GABRB GABRD gamma-aminobutyric acid type A receptor subunit delta GABRE gamma-aminobutyric acid type A receptor subunit epsilon GABRG GABRG GABRG GABRP gamma-aminobutyric acid type A receptor subunit pi GABRQ gamma-aminobutyric acid type A receptor subunit theta	Alprazolam 💬 Morphine addiction × Name Other Names Alprazolam Alprazolam (JP18/USP/INN) Xanax (TN) XANAX ALPRAZOLAM ALPRAZOLAM C-IV	Alprazolam	[2]  8 , 75 💬 357. Morphine addiction × Disease ID Name  8  Huntington disease;Huntington chorea; 75 Cushing disease;Cushing syndrome;
358	Morphine addiction 💬	[4] PDE4, PDE4, PDE4, PDE4 💬 Morphine addiction × Name Full Name PDE4 PDE4 PDE4 PDE4	Rolipram 💬 Morphine addiction × Name Other Names Rolipram Rolipram (JAN/USAN/INN)	Rolipram	[2]  8 , 13 💬 358. Morphine addiction × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
359	mTOR signaling pathway 💬	[2] PRKAA, PRKAA 💬 mTOR signaling pathway × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 mTOR signaling pathway × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 359. mTOR signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
360	mTOR signaling pathway 💬	[2] PRKAA, PRKAA 💬 mTOR signaling pathway × Name Full Name PRKAA PRKAA	Metformin 💬 mTOR signaling pathway × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 359. mTOR signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
361	Neuroactive ligand signaling 💬	[6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand signaling × Name Full Name ACHE acetylcholinesterase (Yt blood group) GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Neuroactive ligand signaling × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 361. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
362	Neuroactive ligand signaling 💬	[6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand signaling × Name Full Name ACHE acetylcholinesterase (Yt blood group) GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Neuroactive ligand signaling × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 361. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
363	Neuroactive ligand signaling 💬	[4] ADRA1A, ADRA1B, ADRA1D, ADRB1 💬 Neuroactive ligand signaling × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1	Bevantolol hydrochloride 💬 Neuroactive ligand signaling × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 363. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
364	Neuroactive ligand signaling 💬	[11] ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2, HTR2, HTR2, HTR6 💬 Neuroactive ligand signaling × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D DRD2 dopamine receptor D2 DRD3 dopamine receptor D3 DRD4 dopamine receptor D4 HRH1 histamine receptor H1 HTR2 HTR2 HTR2 HTR6 5-hydroxytryptamine receptor 6	Olanzapine 💬 Neuroactive ligand signaling × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 364. Neuroactive ligand signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
365	Neuroactive ligand signaling 💬	[11] ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2, HTR2, HTR2, HTR6 💬 Neuroactive ligand signaling × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D DRD2 dopamine receptor D2 DRD3 dopamine receptor D3 DRD4 dopamine receptor D4 HRH1 histamine receptor H1 HTR2 HTR2 HTR2 HTR6 5-hydroxytryptamine receptor 6	Olanzapine pamoate 💬 Neuroactive ligand signaling × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 364. Neuroactive ligand signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
366	Neuroactive ligand signaling 💬	[3] ADRA2A, ADRA2B, ADRA2C 💬 Neuroactive ligand signaling × Name Full Name ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C	Rilmenidine 💬 Neuroactive ligand signaling × Name Other Names Rilmenidine Rilmenidine (INN) Hyperium (TN)	Rilmenidine	[1]  8  💬 366. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
367	Neuroactive ligand signaling 💬	[1] DRD2 💬 Neuroactive ligand signaling × Name Full Name DRD2 dopamine receptor D2	Haloperidol 💬 Neuroactive ligand signaling × Name Other Names Haloperidol Haloperidol (JP18/USP/INN) Haldol (TN)	Haloperidol	[1]  8  💬 367. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
368	Neuroactive ligand signaling 💬	[1] DRD2 💬 Neuroactive ligand signaling × Name Full Name DRD2 dopamine receptor D2	Haloperidol decanoate 💬 Neuroactive ligand signaling × Name Other Names Haloperidol decanoate Haloperidol decanoate (JAN/USP) Halomonth (TN) HALDOL DECANOATE HALOPERIDOL DECANOATE	Haloperidol	[1]  8  💬 367. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
369	Neuroactive ligand signaling 💬	[1] DRD2 💬 Neuroactive ligand signaling × Name Full Name DRD2 dopamine receptor D2	Haloperidol lactate 💬 Neuroactive ligand signaling × Name Other Names Haloperidol lactate Haloperidol lactate Haldol (TN)	Haloperidol	[1]  8  💬 367. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
370	Neuroactive ligand signaling 💬	[1] DRD2 💬 Neuroactive ligand signaling × Name Full Name DRD2 dopamine receptor D2	Pridopidine 💬 Neuroactive ligand signaling × Name Other Names Pridopidine Pridopidine (USAN/INN)	Pridopidine	[3]  2 ,  6 ,  8  💬 370. Neuroactive ligand signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
371	Neuroactive ligand signaling 💬	[1] DRD2 💬 Neuroactive ligand signaling × Name Full Name DRD2 dopamine receptor D2	Pridopidine hydrochloride 💬 Neuroactive ligand signaling × Name Other Names Pridopidine hydrochloride Pridopidine hydrochloride (USAN)	Pridopidine	[3]  2 ,  6 ,  8  💬 370. Neuroactive ligand signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
372	Neuroactive ligand signaling 💬	[2] DRD2, HTR2 💬 Neuroactive ligand signaling × Name Full Name DRD2 dopamine receptor D2 HTR2	Risperidone 💬 Neuroactive ligand signaling × Name Other Names Risperidone Risperidone (JP18/USP/INN) Risperdal (TN) PERSERIS RISPERDAL CONSTA RISPERIDONE RYKINDO UZEDY	Risperidone	[3]  8 , 156, 187 💬 372. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea; 156 Rett syndrome; 187 Kabuki syndrome;
373	Neuroactive ligand signaling 💬	[16] GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Neuroactive ligand signaling × Name Full Name GABRA GABRA GABRA GABRA GABRA GABRA GABRB GABRB GABRB GABRD gamma-aminobutyric acid type A receptor subunit delta GABRE gamma-aminobutyric acid type A receptor subunit epsilon GABRG GABRG GABRG GABRP gamma-aminobutyric acid type A receptor subunit pi GABRQ gamma-aminobutyric acid type A receptor subunit theta	Alprazolam 💬 Neuroactive ligand signaling × Name Other Names Alprazolam Alprazolam (JP18/USP/INN) Xanax (TN) XANAX ALPRAZOLAM ALPRAZOLAM C-IV	Alprazolam	[2]  8 , 75 💬 373. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea; 75 Cushing disease;Cushing syndrome;
374	Neuroactive ligand signaling 💬	[14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand signaling × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIA3 glutamate ionotropic receptor AMPA type subunit 3 GRIA4 glutamate ionotropic receptor AMPA type subunit 4 GRIK1 glutamate ionotropic receptor kainate type subunit 1 GRIK2 glutamate ionotropic receptor kainate type subunit 2 GRIK3 glutamate ionotropic receptor kainate type subunit 3 GRIK4 glutamate ionotropic receptor kainate type subunit 4 GRIK5 glutamate ionotropic receptor kainate type subunit 5 GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Neuroactive ligand signaling × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 374. Neuroactive ligand signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
375	Neuroactive ligand signaling 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand signaling × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Neuroactive ligand signaling × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 375. Neuroactive ligand signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
376	Neuroactive ligand signaling 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand signaling × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Neuroactive ligand signaling × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 375. Neuroactive ligand signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
377	Neuroactive ligand signaling 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand signaling × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan hydrobromide 💬 Neuroactive ligand signaling × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 377. Neuroactive ligand signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
378	Neuroactive ligand signaling 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand signaling × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan 💬 Neuroactive ligand signaling × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 377. Neuroactive ligand signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
379	Neuroactive ligand signaling 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand signaling × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Neuroactive ligand signaling × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 379. Neuroactive ligand signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
380	Neuroactive ligand signaling 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand signaling × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Neuroactive ligand signaling × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 379. Neuroactive ligand signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
381	Neuroactive ligand signaling 💬	[1] SLC18A1_2 💬 Neuroactive ligand signaling × Name Full Name SLC18A1_2	Deutetrabenazine 💬 Neuroactive ligand signaling × Name Other Names Deutetrabenazine Deutetrabenazine (USAN/INN) Austedo (TN) DEUTETRABENAZINE	Deutetrabenazine	[1]  8  💬 381. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
382	Neuroactive ligand signaling 💬	[1] SLC18A1_2 💬 Neuroactive ligand signaling × Name Full Name SLC18A1_2	Tetrabenazine 💬 Neuroactive ligand signaling × Name Other Names Tetrabenazine Tetrabenazine (JAN/INN) Nitoman (TN) Xenazine (TN) XENAZINE TETRABENAZINE	Tetrabenazine	[1]  8  💬 382. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
383	Neuroactive ligand signaling 💬	[1] SLC18A1_2 💬 Neuroactive ligand signaling × Name Full Name SLC18A1_2	Valbenazine 💬 Neuroactive ligand signaling × Name Other Names Valbenazine Valbenazine (USAN/INN)	Valbenazine	[1]  8  💬 383. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
384	Neuroactive ligand signaling 💬	[1] SLC18A1_2 💬 Neuroactive ligand signaling × Name Full Name SLC18A1_2	Valbenazine tosylate 💬 Neuroactive ligand signaling × Name Other Names Valbenazine tosylate Valbenazine tosylate (USAN) Valbenazine tosilate (JAN) Valbenazine ditosylate Ingrezza (TN) Dysval (TN) VALBENAZINE	Valbenazine	[1]  8  💬 383. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
385	Neuroactive ligand signaling 💬	[1] SLC6A2 💬 Neuroactive ligand signaling × Name Full Name SLC6A2 solute carrier family 6 member 2	Atomoxetine hydrochloride 💬 Neuroactive ligand signaling × Name Other Names Atomoxetine hydrochloride Atomoxetine hydrochloride (JAN/USP) Tomoxetine hydrochloride Strattera (TN) STRATTERA ATOMOXETINE ATOMOXETINE HYDROCHLORIDE	Atomoxetine	[4]  6 ,  8 , 13, 230 💬 385. Neuroactive ligand signaling × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 230 Alveolar hypoventilation syndrome;AHS;Hypoventilation syndrome;
386	Neuroactive ligand signaling 💬	[1] SLC6A2 💬 Neuroactive ligand signaling × Name Full Name SLC6A2 solute carrier family 6 member 2	Atomoxetine 💬 Neuroactive ligand signaling × Name Other Names Atomoxetine Atomoxetine (USP/INN) Tomoxetine	Atomoxetine	[4]  6 ,  8 , 13, 230 💬 385. Neuroactive ligand signaling × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 230 Alveolar hypoventilation syndrome;AHS;Hypoventilation syndrome;
387	Neuroactive ligand signaling 💬	[2] SLC6A2, SLC6A3 💬 Neuroactive ligand signaling × Name Full Name SLC6A2 solute carrier family 6 member 2 SLC6A3 solute carrier family 6 member 3	Bupropion hydrochloride 💬 Neuroactive ligand signaling × Name Other Names Bupropion hydrochloride Bupropion hydrochloride (JAN/USP) Wellbutrin (TN) Zyban (TN) FORFIVO WELLBUTRIN BUPROPION BUPROPION HCL BUPROPION HCL ER BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE SR	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 387. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
388	Neuroactive ligand signaling 💬	[2] SLC6A2, SLC6A3 💬 Neuroactive ligand signaling × Name Full Name SLC6A2 solute carrier family 6 member 2 SLC6A3 solute carrier family 6 member 3	Bupropion 💬 Neuroactive ligand signaling × Name Other Names Bupropion Bupropion (INN)	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 387. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
389	Neuroactive ligand signaling 💬	[2] SLC6A2, SLC6A3 💬 Neuroactive ligand signaling × Name Full Name SLC6A2 solute carrier family 6 member 2 SLC6A3 solute carrier family 6 member 3	Bupropion hydrobromide 💬 Neuroactive ligand signaling × Name Other Names Bupropion hydrobromide Bupropion hydrobromide (USAN) Aplenzin (TN) APLENZIN	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 387. Neuroactive ligand signaling × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
390	Neuroactive ligand-receptor interaction 💬	[4] ADRA1A, ADRA1B, ADRA1D, ADRB1 💬 Neuroactive ligand-receptor interaction × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1	Bevantolol hydrochloride 💬 Neuroactive ligand-receptor interaction × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 390. Neuroactive ligand-receptor interaction × Disease ID Name  8  Huntington disease;Huntington chorea;
391	Neuroactive ligand-receptor interaction 💬	[11] ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2, HTR2, HTR2, HTR6 💬 Neuroactive ligand-receptor interaction × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D DRD2 dopamine receptor D2 DRD3 dopamine receptor D3 DRD4 dopamine receptor D4 HRH1 histamine receptor H1 HTR2 HTR2 HTR2 HTR6 5-hydroxytryptamine receptor 6	Olanzapine pamoate 💬 Neuroactive ligand-receptor interaction × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 391. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
392	Neuroactive ligand-receptor interaction 💬	[11] ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2, HTR2, HTR2, HTR6 💬 Neuroactive ligand-receptor interaction × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D DRD2 dopamine receptor D2 DRD3 dopamine receptor D3 DRD4 dopamine receptor D4 HRH1 histamine receptor H1 HTR2 HTR2 HTR2 HTR6 5-hydroxytryptamine receptor 6	Olanzapine 💬 Neuroactive ligand-receptor interaction × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 391. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
393	Neuroactive ligand-receptor interaction 💬	[3] ADRA2A, ADRA2B, ADRA2C 💬 Neuroactive ligand-receptor interaction × Name Full Name ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C	Rilmenidine 💬 Neuroactive ligand-receptor interaction × Name Other Names Rilmenidine Rilmenidine (INN) Hyperium (TN)	Rilmenidine	[1]  8  💬 393. Neuroactive ligand-receptor interaction × Disease ID Name  8  Huntington disease;Huntington chorea;
394	Neuroactive ligand-receptor interaction 💬	[2] CNR1, CNR2 💬 Neuroactive ligand-receptor interaction × Name Full Name CNR1 cannabinoid receptor 1 CNR2 cannabinoid receptor 2	Cannabidiol 💬 Neuroactive ligand-receptor interaction × Name Other Names Cannabidiol Cannabidiol (JAN/USAN/INN) CBD Epidiolex (TN) EPIDIOLEX	Cannabidiol	[20]  6 ,  8 , 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 394. Neuroactive ligand-receptor interaction × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 36 Epidermolysis bullosa;Kindler syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 95 Autoimmune hepatitis; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 140 Dorabe syndrome;Dravet syndrome; 144 Lennox-Gastaut syndrome; 145 West syndrome;Infantile spasm;Infantile spasms;Infantile spasms syndrome;Infantile epileptic spasms;Infantile epileptic spasms syndrome; 156 Rett syndrome; 157 Sturge-Weber syndrome;Síndrome de Sturge-Weber; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 193 Prader-Willi syndrome; 206 Fragile X syndrome; 226 Interstitial cystitis with Hunners ulcer;Interstitial cystitis; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica;
395	Neuroactive ligand-receptor interaction 💬	[2] CNR1, CNR2 💬 Neuroactive ligand-receptor interaction × Name Full Name CNR1 cannabinoid receptor 1 CNR2 cannabinoid receptor 2	Dronabinol 💬 Neuroactive ligand-receptor interaction × Name Other Names Dronabinol Dronabinol (USP/INN) Tetrahydrocannabinol THC Marinol (TN) DRONABINOL MARINOL SYNDROS	Dronabinol	[8]  2 ,  8 , 13, 36, 46, 96, 271, 298 💬 395. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 36 Epidermolysis bullosa;Kindler syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 298 Hereditary pancreatitis;Chronic pancreatitis;
396	Neuroactive ligand-receptor interaction 💬	[1] DRD2 💬 Neuroactive ligand-receptor interaction × Name Full Name DRD2 dopamine receptor D2	Haloperidol 💬 Neuroactive ligand-receptor interaction × Name Other Names Haloperidol Haloperidol (JP18/USP/INN) Haldol (TN)	Haloperidol	[1]  8  💬 396. Neuroactive ligand-receptor interaction × Disease ID Name  8  Huntington disease;Huntington chorea;
397	Neuroactive ligand-receptor interaction 💬	[1] DRD2 💬 Neuroactive ligand-receptor interaction × Name Full Name DRD2 dopamine receptor D2	Haloperidol decanoate 💬 Neuroactive ligand-receptor interaction × Name Other Names Haloperidol decanoate Haloperidol decanoate (JAN/USP) Halomonth (TN) HALDOL DECANOATE HALOPERIDOL DECANOATE	Haloperidol	[1]  8  💬 396. Neuroactive ligand-receptor interaction × Disease ID Name  8  Huntington disease;Huntington chorea;
398	Neuroactive ligand-receptor interaction 💬	[1] DRD2 💬 Neuroactive ligand-receptor interaction × Name Full Name DRD2 dopamine receptor D2	Haloperidol lactate 💬 Neuroactive ligand-receptor interaction × Name Other Names Haloperidol lactate Haloperidol lactate Haldol (TN)	Haloperidol	[1]  8  💬 396. Neuroactive ligand-receptor interaction × Disease ID Name  8  Huntington disease;Huntington chorea;
399	Neuroactive ligand-receptor interaction 💬	[1] DRD2 💬 Neuroactive ligand-receptor interaction × Name Full Name DRD2 dopamine receptor D2	Pridopidine 💬 Neuroactive ligand-receptor interaction × Name Other Names Pridopidine Pridopidine (USAN/INN)	Pridopidine	[3]  2 ,  6 ,  8  💬 399. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
400	Neuroactive ligand-receptor interaction 💬	[1] DRD2 💬 Neuroactive ligand-receptor interaction × Name Full Name DRD2 dopamine receptor D2	Pridopidine hydrochloride 💬 Neuroactive ligand-receptor interaction × Name Other Names Pridopidine hydrochloride Pridopidine hydrochloride (USAN)	Pridopidine	[3]  2 ,  6 ,  8  💬 399. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
401	Neuroactive ligand-receptor interaction 💬	[2] DRD2, HTR2 💬 Neuroactive ligand-receptor interaction × Name Full Name DRD2 dopamine receptor D2 HTR2	Risperidone 💬 Neuroactive ligand-receptor interaction × Name Other Names Risperidone Risperidone (JP18/USP/INN) Risperdal (TN) PERSERIS RISPERDAL CONSTA RISPERIDONE RYKINDO UZEDY	Risperidone	[3]  8 , 156, 187 💬 401. Neuroactive ligand-receptor interaction × Disease ID Name  8  Huntington disease;Huntington chorea; 156 Rett syndrome; 187 Kabuki syndrome;
402	Neuroactive ligand-receptor interaction 💬	[16] GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Neuroactive ligand-receptor interaction × Name Full Name GABRA GABRA GABRA GABRA GABRA GABRA GABRB GABRB GABRB GABRD gamma-aminobutyric acid type A receptor subunit delta GABRE gamma-aminobutyric acid type A receptor subunit epsilon GABRG GABRG GABRG GABRP gamma-aminobutyric acid type A receptor subunit pi GABRQ gamma-aminobutyric acid type A receptor subunit theta	Alprazolam 💬 Neuroactive ligand-receptor interaction × Name Other Names Alprazolam Alprazolam (JP18/USP/INN) Xanax (TN) XANAX ALPRAZOLAM ALPRAZOLAM C-IV	Alprazolam	[2]  8 , 75 💬 402. Neuroactive ligand-receptor interaction × Disease ID Name  8  Huntington disease;Huntington chorea; 75 Cushing disease;Cushing syndrome;
403	Neuroactive ligand-receptor interaction 💬	[14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand-receptor interaction × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIA3 glutamate ionotropic receptor AMPA type subunit 3 GRIA4 glutamate ionotropic receptor AMPA type subunit 4 GRIK1 glutamate ionotropic receptor kainate type subunit 1 GRIK2 glutamate ionotropic receptor kainate type subunit 2 GRIK3 glutamate ionotropic receptor kainate type subunit 3 GRIK4 glutamate ionotropic receptor kainate type subunit 4 GRIK5 glutamate ionotropic receptor kainate type subunit 5 GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Neuroactive ligand-receptor interaction × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 403. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
404	Neuroactive ligand-receptor interaction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand-receptor interaction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Neuroactive ligand-receptor interaction × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 404. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
405	Neuroactive ligand-receptor interaction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand-receptor interaction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Neuroactive ligand-receptor interaction × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 404. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
406	Neuroactive ligand-receptor interaction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand-receptor interaction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan hydrobromide 💬 Neuroactive ligand-receptor interaction × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 406. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
407	Neuroactive ligand-receptor interaction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand-receptor interaction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan 💬 Neuroactive ligand-receptor interaction × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 406. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
408	Neuroactive ligand-receptor interaction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand-receptor interaction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Neuroactive ligand-receptor interaction × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 408. Neuroactive ligand-receptor interaction × Disease ID Name  8  Huntington disease;Huntington chorea;
409	Neuroactive ligand-receptor interaction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand-receptor interaction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Neuroactive ligand-receptor interaction × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 408. Neuroactive ligand-receptor interaction × Disease ID Name  8  Huntington disease;Huntington chorea;
410	Neuroactive ligand-receptor interaction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand-receptor interaction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Neuroactive ligand-receptor interaction × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 410. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
411	Neuroactive ligand-receptor interaction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Neuroactive ligand-receptor interaction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Neuroactive ligand-receptor interaction × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 410. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
412	Neuroactive ligand-receptor interaction 💬	[2] MTNR1A, MTNR1B 💬 Neuroactive ligand-receptor interaction × Name Full Name MTNR1A melatonin receptor 1A MTNR1B melatonin receptor 1B	Melatonin 💬 Neuroactive ligand-receptor interaction × Name Other Names Melatonin Melatonin (JAN) Melatonina (TN) Melatobel (TN)	Melatonin	[17]  2 ,  6 ,  8 , 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202, 265 💬 412. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 37 Generalised pustular psoriasis;GPP;Pustular psoriasis;Herpetic impetigo; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 72 Pituitary ADH secretion disorder;Inappropriate antidiuretic hormone secretion;Syndrome of inappropriate secretion of antidiuretic hormone;Inappropriate ADH syndrome;Syndrome of inappropriate ADH;Central diabetes insipidus;Syndrome of inappropriate secretion of ADH;SIADH; 78 Hypopituitarism;Anterior pituitary hypothyroidism; 86 Pulmonary arterial hypertension;PAH; 90 Retinitis pigmentosa;Rod dystrophy;Cone-rod dystrophy;Rod-Cone Dystrophy; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 145 West syndrome;Infantile spasm;Infantile spasms;Infantile spasms syndrome;Infantile epileptic spasms;Infantile epileptic spasms syndrome; 149 Hemiconvulsion hemiplegia epilepsy syndrome;One side convulsions;Hemiplegia;Epilepsy syndrome; 202 Smith-Magenis syndrome; 265 Lipodystrophy;
413	Neuroactive ligand-receptor interaction 💬	[2] MTNR1A, MTNR1B 💬 Neuroactive ligand-receptor interaction × Name Full Name MTNR1A melatonin receptor 1A MTNR1B melatonin receptor 1B	Ramelteon 💬 Neuroactive ligand-receptor interaction × Name Other Names Ramelteon Ramelteon (JAN/USAN/INN) Rozerem (TN) ROZEREM RAMELTEON	Ramelteon	[3]  6 ,  8 , 46 💬 413. Neuroactive ligand-receptor interaction × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV;
414	Neurotrophin signaling pathway 💬	[1] ABL1 💬 Neurotrophin signaling pathway × Name Full Name ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase	Nilotinib 💬 Neurotrophin signaling pathway × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 414. Neurotrophin signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
415	Neurotrophin signaling pathway 💬	[4] P38, P38, P38, P38 💬 Neurotrophin signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Neurotrophin signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 415. Neurotrophin signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
416	Neutrophil extracellular trap formation 💬	[4] P38, P38, P38, P38 💬 Neutrophil extracellular trap formation × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Neutrophil extracellular trap formation × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 416. Neutrophil extracellular trap formation × Disease ID Name  8  Huntington disease;Huntington chorea;
417	Nicotine addiction 💬	[16] GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Nicotine addiction × Name Full Name GABRA GABRA GABRA GABRA GABRA GABRA GABRB GABRB GABRB GABRD gamma-aminobutyric acid type A receptor subunit delta GABRE gamma-aminobutyric acid type A receptor subunit epsilon GABRG GABRG GABRG GABRP gamma-aminobutyric acid type A receptor subunit pi GABRQ gamma-aminobutyric acid type A receptor subunit theta	Alprazolam 💬 Nicotine addiction × Name Other Names Alprazolam Alprazolam (JP18/USP/INN) Xanax (TN) XANAX ALPRAZOLAM ALPRAZOLAM C-IV	Alprazolam	[2]  8 , 75 💬 417. Nicotine addiction × Disease ID Name  8  Huntington disease;Huntington chorea; 75 Cushing disease;Cushing syndrome;
418	Nicotine addiction 💬	[9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Nicotine addiction × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIA3 glutamate ionotropic receptor AMPA type subunit 3 GRIA4 glutamate ionotropic receptor AMPA type subunit 4 GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Nicotine addiction × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 418. Nicotine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
419	Nicotine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Nicotine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Nicotine addiction × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 419. Nicotine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
420	Nicotine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Nicotine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Nicotine addiction × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 419. Nicotine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
421	Nicotine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Nicotine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan hydrobromide 💬 Nicotine addiction × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 421. Nicotine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
422	Nicotine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Nicotine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan 💬 Nicotine addiction × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 421. Nicotine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
423	Nicotine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Nicotine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Nicotine addiction × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 423. Nicotine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
424	Nicotine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Nicotine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Nicotine addiction × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 423. Nicotine addiction × Disease ID Name  8  Huntington disease;Huntington chorea;
425	Nicotine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Nicotine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Nicotine addiction × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 425. Nicotine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
426	Nicotine addiction 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Nicotine addiction × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Nicotine addiction × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 425. Nicotine addiction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
427	NOD-like receptor signaling pathway 💬	[4] P38, P38, P38, P38 💬 NOD-like receptor signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 NOD-like receptor signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 427. NOD-like receptor signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
428	Non-alcoholic fatty liver disease 💬	[1] NR1C1 💬 Non-alcoholic fatty liver disease × Name Full Name NR1C1	Fenofibrate 💬 Non-alcoholic fatty liver disease × Name Other Names Fenofibrate Fenofibrate (JP18/USP/INN) Antara (TN) Lipantil (TN) Lipofen (TN) Tricor (TN) Triglide (TN) ANTARA LIPOFEN TRICOR FENOFIBRATE	Fenofibrate	[6]  8 , 79, 93, 94, 97, 265 💬 428. Non-alcoholic fatty liver disease × Disease ID Name  8  Huntington disease;Huntington chorea; 79 Homozygous familial hypercholesterolemia;Familial hypercholesterolaemia; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 265 Lipodystrophy;
429	Non-alcoholic fatty liver disease 💬	[4] P38, P38, P38, P38 💬 Non-alcoholic fatty liver disease × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Non-alcoholic fatty liver disease × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 429. Non-alcoholic fatty liver disease × Disease ID Name  8  Huntington disease;Huntington chorea;
430	Non-alcoholic fatty liver disease 💬	[2] PRKAA, PRKAA 💬 Non-alcoholic fatty liver disease × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Non-alcoholic fatty liver disease × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 430. Non-alcoholic fatty liver disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
431	Non-alcoholic fatty liver disease 💬	[2] PRKAA, PRKAA 💬 Non-alcoholic fatty liver disease × Name Full Name PRKAA PRKAA	Metformin 💬 Non-alcoholic fatty liver disease × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 430. Non-alcoholic fatty liver disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
432	Oocyte meiosis 💬	[4] P38, P38, P38, P38 💬 Oocyte meiosis × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Oocyte meiosis × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 432. Oocyte meiosis × Disease ID Name  8  Huntington disease;Huntington chorea;
433	Osteoclast differentiation 💬	[4] P38, P38, P38, P38 💬 Osteoclast differentiation × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Osteoclast differentiation × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 433. Osteoclast differentiation × Disease ID Name  8  Huntington disease;Huntington chorea;
434	Oxytocin signaling pathway 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Oxytocin signaling pathway × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Oxytocin signaling pathway × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 434. Oxytocin signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
435	Oxytocin signaling pathway 💬	[2] PRKAA, PRKAA 💬 Oxytocin signaling pathway × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Oxytocin signaling pathway × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 435. Oxytocin signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
436	Oxytocin signaling pathway 💬	[2] PRKAA, PRKAA 💬 Oxytocin signaling pathway × Name Full Name PRKAA PRKAA	Metformin 💬 Oxytocin signaling pathway × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 435. Oxytocin signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
437	Pancreatic secretion 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Pancreatic secretion × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Pancreatic secretion × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 437. Pancreatic secretion × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
438	Parathyroid hormone synthesis, secretion and action 💬	[4] PDE4, PDE4, PDE4, PDE4 💬 Parathyroid hormone synthesis, secretion and action × Name Full Name PDE4 PDE4 PDE4 PDE4	Rolipram 💬 Parathyroid hormone synthesis, secretion and action × Name Other Names Rolipram Rolipram (JAN/USAN/INN)	Rolipram	[2]  8 , 13 💬 438. Parathyroid hormone synthesis, secretion and action × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
439	Parkinson disease 💬	[1] DRD2 💬 Parkinson disease × Name Full Name DRD2 dopamine receptor D2	Haloperidol 💬 Parkinson disease × Name Other Names Haloperidol Haloperidol (JP18/USP/INN) Haldol (TN)	Haloperidol	[1]  8  💬 439. Parkinson disease × Disease ID Name  8  Huntington disease;Huntington chorea;
440	Parkinson disease 💬	[1] DRD2 💬 Parkinson disease × Name Full Name DRD2 dopamine receptor D2	Haloperidol decanoate 💬 Parkinson disease × Name Other Names Haloperidol decanoate Haloperidol decanoate (JAN/USP) Halomonth (TN) HALDOL DECANOATE HALOPERIDOL DECANOATE	Haloperidol	[1]  8  💬 439. Parkinson disease × Disease ID Name  8  Huntington disease;Huntington chorea;
441	Parkinson disease 💬	[1] DRD2 💬 Parkinson disease × Name Full Name DRD2 dopamine receptor D2	Haloperidol lactate 💬 Parkinson disease × Name Other Names Haloperidol lactate Haloperidol lactate Haldol (TN)	Haloperidol	[1]  8  💬 439. Parkinson disease × Disease ID Name  8  Huntington disease;Huntington chorea;
442	Parkinson disease 💬	[1] DRD2 💬 Parkinson disease × Name Full Name DRD2 dopamine receptor D2	Olanzapine 💬 Parkinson disease × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 442. Parkinson disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
443	Parkinson disease 💬	[1] DRD2 💬 Parkinson disease × Name Full Name DRD2 dopamine receptor D2	Olanzapine pamoate 💬 Parkinson disease × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 442. Parkinson disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
444	Parkinson disease 💬	[1] DRD2 💬 Parkinson disease × Name Full Name DRD2 dopamine receptor D2	Pridopidine 💬 Parkinson disease × Name Other Names Pridopidine Pridopidine (USAN/INN)	Pridopidine	[3]  2 ,  6 ,  8  💬 444. Parkinson disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
445	Parkinson disease 💬	[1] DRD2 💬 Parkinson disease × Name Full Name DRD2 dopamine receptor D2	Pridopidine hydrochloride 💬 Parkinson disease × Name Other Names Pridopidine hydrochloride Pridopidine hydrochloride (USAN)	Pridopidine	[3]  2 ,  6 ,  8  💬 444. Parkinson disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
446	Parkinson disease 💬	[1] DRD2 💬 Parkinson disease × Name Full Name DRD2 dopamine receptor D2	Risperidone 💬 Parkinson disease × Name Other Names Risperidone Risperidone (JP18/USP/INN) Risperdal (TN) PERSERIS RISPERDAL CONSTA RISPERIDONE RYKINDO UZEDY	Risperidone	[3]  8 , 156, 187 💬 446. Parkinson disease × Disease ID Name  8  Huntington disease;Huntington chorea; 156 Rett syndrome; 187 Kabuki syndrome;
447	Parkinson disease 💬	[1] SLC18A1_2 💬 Parkinson disease × Name Full Name SLC18A1_2	Deutetrabenazine 💬 Parkinson disease × Name Other Names Deutetrabenazine Deutetrabenazine (USAN/INN) Austedo (TN) DEUTETRABENAZINE	Deutetrabenazine	[1]  8  💬 447. Parkinson disease × Disease ID Name  8  Huntington disease;Huntington chorea;
448	Parkinson disease 💬	[1] SLC18A1_2 💬 Parkinson disease × Name Full Name SLC18A1_2	Tetrabenazine 💬 Parkinson disease × Name Other Names Tetrabenazine Tetrabenazine (JAN/INN) Nitoman (TN) Xenazine (TN) XENAZINE TETRABENAZINE	Tetrabenazine	[1]  8  💬 448. Parkinson disease × Disease ID Name  8  Huntington disease;Huntington chorea;
449	Parkinson disease 💬	[1] SLC18A1_2 💬 Parkinson disease × Name Full Name SLC18A1_2	Valbenazine 💬 Parkinson disease × Name Other Names Valbenazine Valbenazine (USAN/INN)	Valbenazine	[1]  8  💬 449. Parkinson disease × Disease ID Name  8  Huntington disease;Huntington chorea;
450	Parkinson disease 💬	[1] SLC18A1_2 💬 Parkinson disease × Name Full Name SLC18A1_2	Valbenazine tosylate 💬 Parkinson disease × Name Other Names Valbenazine tosylate Valbenazine tosylate (USAN) Valbenazine tosilate (JAN) Valbenazine ditosylate Ingrezza (TN) Dysval (TN) VALBENAZINE	Valbenazine	[1]  8  💬 449. Parkinson disease × Disease ID Name  8  Huntington disease;Huntington chorea;
451	Parkinson disease 💬	[1] SLC6A3 💬 Parkinson disease × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion hydrochloride 💬 Parkinson disease × Name Other Names Bupropion hydrochloride Bupropion hydrochloride (JAN/USP) Wellbutrin (TN) Zyban (TN) FORFIVO WELLBUTRIN BUPROPION BUPROPION HCL BUPROPION HCL ER BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE SR	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 451. Parkinson disease × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
452	Parkinson disease 💬	[1] SLC6A3 💬 Parkinson disease × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion 💬 Parkinson disease × Name Other Names Bupropion Bupropion (INN)	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 451. Parkinson disease × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
453	Parkinson disease 💬	[1] SLC6A3 💬 Parkinson disease × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion hydrobromide 💬 Parkinson disease × Name Other Names Bupropion hydrobromide Bupropion hydrobromide (USAN) Aplenzin (TN) APLENZIN	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 451. Parkinson disease × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
454	Pathogenic Escherichia coli infection 💬	[1] ABL1 💬 Pathogenic Escherichia coli infection × Name Full Name ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase	Nilotinib 💬 Pathogenic Escherichia coli infection × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 454. Pathogenic Escherichia coli infection × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
455	Pathogenic Escherichia coli infection 💬	[4] P38, P38, P38, P38 💬 Pathogenic Escherichia coli infection × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Pathogenic Escherichia coli infection × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 455. Pathogenic Escherichia coli infection × Disease ID Name  8  Huntington disease;Huntington chorea;
456	Pathways in cancer 💬	[4] ABL1, KIT, PDGFRA, PDGFRB 💬 Pathways in cancer × Name Full Name ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase KIT KIT proto-oncogene, receptor tyrosine kinase PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 Pathways in cancer × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 456. Pathways in cancer × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
457	Pathways in cancer 💬	[1] NQO1 💬 Pathways in cancer × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1	Warfarin sodium 💬 Pathways in cancer × Name Other Names Warfarin sodium Warfarin sodium (USP) Coumadin (TN) Jantoven (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 457. Pathways in cancer × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
458	Pathways in cancer 💬	[1] NQO1 💬 Pathways in cancer × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1	Warfarin potassium 💬 Pathways in cancer × Name Other Names Warfarin potassium Warfarin potassium (JP18) Athrombin-K (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 457. Pathways in cancer × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
459	Pathways in cancer 💬	[1] NQO1 💬 Pathways in cancer × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1	Warfarin 💬 Pathways in cancer × Name Other Names Warfarin Warfarin (INN) Warfarine Choice (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 457. Pathways in cancer × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
460	Pathways of neurodegeneration - multiple diseases 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 460. Pathways of neurodegeneration - multiple diseases × Disease ID Name  8  Huntington disease;Huntington chorea;
461	Pathways of neurodegeneration - multiple diseases 💬	[9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIA3 glutamate ionotropic receptor AMPA type subunit 3 GRIA4 glutamate ionotropic receptor AMPA type subunit 4 GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 461. Pathways of neurodegeneration - multiple diseases × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
462	Pathways of neurodegeneration - multiple diseases 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 462. Pathways of neurodegeneration - multiple diseases × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
463	Pathways of neurodegeneration - multiple diseases 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 462. Pathways of neurodegeneration - multiple diseases × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
464	Pathways of neurodegeneration - multiple diseases 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 464. Pathways of neurodegeneration - multiple diseases × Disease ID Name  8  Huntington disease;Huntington chorea;
465	Pathways of neurodegeneration - multiple diseases 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 464. Pathways of neurodegeneration - multiple diseases × Disease ID Name  8  Huntington disease;Huntington chorea;
466	Pathways of neurodegeneration - multiple diseases 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 466. Pathways of neurodegeneration - multiple diseases × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
467	Pathways of neurodegeneration - multiple diseases 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 466. Pathways of neurodegeneration - multiple diseases × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
468	Pathways of neurodegeneration - multiple diseases 💬	[6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D SIGMAR1 sigma non-opioid intracellular receptor 1	Dextromethorphan hydrobromide 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 468. Pathways of neurodegeneration - multiple diseases × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
469	Pathways of neurodegeneration - multiple diseases 💬	[6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D SIGMAR1 sigma non-opioid intracellular receptor 1	Dextromethorphan 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 468. Pathways of neurodegeneration - multiple diseases × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
470	Pathways of neurodegeneration - multiple diseases 💬	[1] HD 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name HD	Tominersen 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Tominersen Tominersen (USAN/INN)	Tominersen	[1]  8  💬 470. Pathways of neurodegeneration - multiple diseases × Disease ID Name  8  Huntington disease;Huntington chorea;
471	Pathways of neurodegeneration - multiple diseases 💬	[4] P38, P38, P38, P38 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 471. Pathways of neurodegeneration - multiple diseases × Disease ID Name  8  Huntington disease;Huntington chorea;
472	Pathways of neurodegeneration - multiple diseases 💬	[1] SLC6A3 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion hydrochloride 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Bupropion hydrochloride Bupropion hydrochloride (JAN/USP) Wellbutrin (TN) Zyban (TN) FORFIVO WELLBUTRIN BUPROPION BUPROPION HCL BUPROPION HCL ER BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE SR	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 472. Pathways of neurodegeneration - multiple diseases × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
473	Pathways of neurodegeneration - multiple diseases 💬	[1] SLC6A3 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Bupropion Bupropion (INN)	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 472. Pathways of neurodegeneration - multiple diseases × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
474	Pathways of neurodegeneration - multiple diseases 💬	[1] SLC6A3 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name SLC6A3 solute carrier family 6 member 3	Bupropion hydrobromide 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Bupropion hydrobromide Bupropion hydrobromide (USAN) Aplenzin (TN) APLENZIN	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 472. Pathways of neurodegeneration - multiple diseases × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
475	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[4] P38, P38, P38, P38 💬 PD-L1 expression and PD-1 checkpoint pathway in cancer × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 PD-L1 expression and PD-1 checkpoint pathway in cancer × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 475. PD-L1 expression and PD-1 checkpoint pathway in cancer × Disease ID Name  8  Huntington disease;Huntington chorea;
476	Pertussis 💬	[4] P38, P38, P38, P38 💬 Pertussis × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Pertussis × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 476. Pertussis × Disease ID Name  8  Huntington disease;Huntington chorea;
477	Phospholipase D signaling pathway 💬	[3] KIT, PDGFRA, PDGFRB 💬 Phospholipase D signaling pathway × Name Full Name KIT KIT proto-oncogene, receptor tyrosine kinase PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 Phospholipase D signaling pathway × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 477. Phospholipase D signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
478	PI3K-Akt signaling pathway 💬	[3] KIT, PDGFRA, PDGFRB 💬 PI3K-Akt signaling pathway × Name Full Name KIT KIT proto-oncogene, receptor tyrosine kinase PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 PI3K-Akt signaling pathway × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 478. PI3K-Akt signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
479	PI3K-Akt signaling pathway 💬	[2] PRKAA, PRKAA 💬 PI3K-Akt signaling pathway × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 PI3K-Akt signaling pathway × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 479. PI3K-Akt signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
480	PI3K-Akt signaling pathway 💬	[2] PRKAA, PRKAA 💬 PI3K-Akt signaling pathway × Name Full Name PRKAA PRKAA	Metformin 💬 PI3K-Akt signaling pathway × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 479. PI3K-Akt signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
481	Platelet activation 💬	[4] P38, P38, P38, P38 💬 Platelet activation × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Platelet activation × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 481. Platelet activation × Disease ID Name  8  Huntington disease;Huntington chorea;
482	PPAR signaling pathway 💬	[1] NR1C1 💬 PPAR signaling pathway × Name Full Name NR1C1	Fenofibrate 💬 PPAR signaling pathway × Name Other Names Fenofibrate Fenofibrate (JP18/USP/INN) Antara (TN) Lipantil (TN) Lipofen (TN) Tricor (TN) Triglide (TN) ANTARA LIPOFEN TRICOR FENOFIBRATE	Fenofibrate	[6]  8 , 79, 93, 94, 97, 265 💬 482. PPAR signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea; 79 Homozygous familial hypercholesterolemia;Familial hypercholesterolaemia; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 265 Lipodystrophy;
483	Prion disease 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Prion disease × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Prion disease × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 483. Prion disease × Disease ID Name  8  Huntington disease;Huntington chorea;
484	Prion disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Prion disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Prion disease × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 484. Prion disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
485	Prion disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Prion disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Prion disease × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 484. Prion disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
486	Prion disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Prion disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan hydrobromide 💬 Prion disease × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 486. Prion disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
487	Prion disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Prion disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan 💬 Prion disease × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 486. Prion disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
488	Prion disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Prion disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Prion disease × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 488. Prion disease × Disease ID Name  8  Huntington disease;Huntington chorea;
489	Prion disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Prion disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Prion disease × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 488. Prion disease × Disease ID Name  8  Huntington disease;Huntington chorea;
490	Prion disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Prion disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Prion disease × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 490. Prion disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
491	Prion disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Prion disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Prion disease × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 490. Prion disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
492	Prion disease 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Prion disease × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Prion disease × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 492. Prion disease × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
493	Prion disease 💬	[4] P38, P38, P38, P38 💬 Prion disease × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Prion disease × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 493. Prion disease × Disease ID Name  8  Huntington disease;Huntington chorea;
494	Progesterone-mediated oocyte maturation 💬	[4] P38, P38, P38, P38 💬 Progesterone-mediated oocyte maturation × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Progesterone-mediated oocyte maturation × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 494. Progesterone-mediated oocyte maturation × Disease ID Name  8  Huntington disease;Huntington chorea;
495	Prolactin signaling pathway 💬	[4] P38, P38, P38, P38 💬 Prolactin signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Prolactin signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 495. Prolactin signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
496	Prostate cancer 💬	[2] PDGFRA, PDGFRB 💬 Prostate cancer × Name Full Name PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 Prostate cancer × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 496. Prostate cancer × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
497	Protein digestion and absorption 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Protein digestion and absorption × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Protein digestion and absorption × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 497. Protein digestion and absorption × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
498	Proteoglycans in cancer 💬	[4] P38, P38, P38, P38 💬 Proteoglycans in cancer × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Proteoglycans in cancer × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 498. Proteoglycans in cancer × Disease ID Name  8  Huntington disease;Huntington chorea;
499	Proximal tubule bicarbonate reclamation 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Proximal tubule bicarbonate reclamation × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Proximal tubule bicarbonate reclamation × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 499. Proximal tubule bicarbonate reclamation × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
500	Purine metabolism 💬	[4] PDE4, PDE4, PDE4, PDE4 💬 Purine metabolism × Name Full Name PDE4 PDE4 PDE4 PDE4	Rolipram 💬 Purine metabolism × Name Other Names Rolipram Rolipram (JAN/USAN/INN)	Rolipram	[2]  8 , 13 💬 500. Purine metabolism × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
501	Rap1 signaling pathway 💬	[1] CNR1 💬 Rap1 signaling pathway × Name Full Name CNR1 cannabinoid receptor 1	Cannabidiol 💬 Rap1 signaling pathway × Name Other Names Cannabidiol Cannabidiol (JAN/USAN/INN) CBD Epidiolex (TN) EPIDIOLEX	Cannabidiol	[20]  6 ,  8 , 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 501. Rap1 signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 36 Epidermolysis bullosa;Kindler syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 95 Autoimmune hepatitis; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 140 Dorabe syndrome;Dravet syndrome; 144 Lennox-Gastaut syndrome; 145 West syndrome;Infantile spasm;Infantile spasms;Infantile spasms syndrome;Infantile epileptic spasms;Infantile epileptic spasms syndrome; 156 Rett syndrome; 157 Sturge-Weber syndrome;Síndrome de Sturge-Weber; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 193 Prader-Willi syndrome; 206 Fragile X syndrome; 226 Interstitial cystitis with Hunners ulcer;Interstitial cystitis; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica;
502	Rap1 signaling pathway 💬	[1] CNR1 💬 Rap1 signaling pathway × Name Full Name CNR1 cannabinoid receptor 1	Dronabinol 💬 Rap1 signaling pathway × Name Other Names Dronabinol Dronabinol (USP/INN) Tetrahydrocannabinol THC Marinol (TN) DRONABINOL MARINOL SYNDROS	Dronabinol	[8]  2 ,  8 , 13, 36, 46, 96, 271, 298 💬 502. Rap1 signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 36 Epidermolysis bullosa;Kindler syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 298 Hereditary pancreatitis;Chronic pancreatitis;
503	Rap1 signaling pathway 💬	[1] DRD2 💬 Rap1 signaling pathway × Name Full Name DRD2 dopamine receptor D2	Haloperidol 💬 Rap1 signaling pathway × Name Other Names Haloperidol Haloperidol (JP18/USP/INN) Haldol (TN)	Haloperidol	[1]  8  💬 503. Rap1 signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
504	Rap1 signaling pathway 💬	[1] DRD2 💬 Rap1 signaling pathway × Name Full Name DRD2 dopamine receptor D2	Haloperidol decanoate 💬 Rap1 signaling pathway × Name Other Names Haloperidol decanoate Haloperidol decanoate (JAN/USP) Halomonth (TN) HALDOL DECANOATE HALOPERIDOL DECANOATE	Haloperidol	[1]  8  💬 503. Rap1 signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
505	Rap1 signaling pathway 💬	[1] DRD2 💬 Rap1 signaling pathway × Name Full Name DRD2 dopamine receptor D2	Haloperidol lactate 💬 Rap1 signaling pathway × Name Other Names Haloperidol lactate Haloperidol lactate Haldol (TN)	Haloperidol	[1]  8  💬 503. Rap1 signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
506	Rap1 signaling pathway 💬	[1] DRD2 💬 Rap1 signaling pathway × Name Full Name DRD2 dopamine receptor D2	Olanzapine 💬 Rap1 signaling pathway × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 506. Rap1 signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
507	Rap1 signaling pathway 💬	[1] DRD2 💬 Rap1 signaling pathway × Name Full Name DRD2 dopamine receptor D2	Olanzapine pamoate 💬 Rap1 signaling pathway × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 506. Rap1 signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
508	Rap1 signaling pathway 💬	[1] DRD2 💬 Rap1 signaling pathway × Name Full Name DRD2 dopamine receptor D2	Pridopidine 💬 Rap1 signaling pathway × Name Other Names Pridopidine Pridopidine (USAN/INN)	Pridopidine	[3]  2 ,  6 ,  8  💬 508. Rap1 signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
509	Rap1 signaling pathway 💬	[1] DRD2 💬 Rap1 signaling pathway × Name Full Name DRD2 dopamine receptor D2	Pridopidine hydrochloride 💬 Rap1 signaling pathway × Name Other Names Pridopidine hydrochloride Pridopidine hydrochloride (USAN)	Pridopidine	[3]  2 ,  6 ,  8  💬 508. Rap1 signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea;
510	Rap1 signaling pathway 💬	[1] DRD2 💬 Rap1 signaling pathway × Name Full Name DRD2 dopamine receptor D2	Risperidone 💬 Rap1 signaling pathway × Name Other Names Risperidone Risperidone (JP18/USP/INN) Risperdal (TN) PERSERIS RISPERDAL CONSTA RISPERIDONE RYKINDO UZEDY	Risperidone	[3]  8 , 156, 187 💬 510. Rap1 signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea; 156 Rett syndrome; 187 Kabuki syndrome;
511	Rap1 signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Rap1 signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Amantadine hydrochloride 💬 Rap1 signaling pathway × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 511. Rap1 signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
512	Rap1 signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Rap1 signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Amantadine 💬 Rap1 signaling pathway × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 511. Rap1 signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
513	Rap1 signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Rap1 signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Dextromethorphan hydrobromide 💬 Rap1 signaling pathway × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 513. Rap1 signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
514	Rap1 signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Rap1 signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Dextromethorphan 💬 Rap1 signaling pathway × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 513. Rap1 signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
515	Rap1 signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Rap1 signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Latrepirdine 💬 Rap1 signaling pathway × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 515. Rap1 signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
516	Rap1 signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Rap1 signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Latrepirdine dihydrochloride 💬 Rap1 signaling pathway × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 515. Rap1 signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
517	Rap1 signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Rap1 signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Memantine hydrochloride 💬 Rap1 signaling pathway × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 517. Rap1 signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
518	Rap1 signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Rap1 signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Memantine 💬 Rap1 signaling pathway × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 517. Rap1 signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
519	Rap1 signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Rap1 signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Riluzole 💬 Rap1 signaling pathway × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 519. Rap1 signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
520	Rap1 signaling pathway 💬	[3] KIT, PDGFRA, PDGFRB 💬 Rap1 signaling pathway × Name Full Name KIT KIT proto-oncogene, receptor tyrosine kinase PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 Rap1 signaling pathway × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 520. Rap1 signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
521	Rap1 signaling pathway 💬	[4] P38, P38, P38, P38 💬 Rap1 signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Rap1 signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 521. Rap1 signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
522	Ras signaling pathway 💬	[4] ABL1, KIT, PDGFRA, PDGFRB 💬 Ras signaling pathway × Name Full Name ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase KIT KIT proto-oncogene, receptor tyrosine kinase PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 Ras signaling pathway × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 522. Ras signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
523	Ras signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Ras signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Amantadine hydrochloride 💬 Ras signaling pathway × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 523. Ras signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
524	Ras signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Ras signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Amantadine 💬 Ras signaling pathway × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 523. Ras signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
525	Ras signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Ras signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Dextromethorphan hydrobromide 💬 Ras signaling pathway × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 525. Ras signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
526	Ras signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Ras signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Dextromethorphan 💬 Ras signaling pathway × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 525. Ras signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
527	Ras signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Ras signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Latrepirdine 💬 Ras signaling pathway × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 527. Ras signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
528	Ras signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Ras signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Latrepirdine dihydrochloride 💬 Ras signaling pathway × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 527. Ras signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
529	Ras signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Ras signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Memantine hydrochloride 💬 Ras signaling pathway × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 529. Ras signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
530	Ras signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Ras signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Memantine 💬 Ras signaling pathway × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 529. Ras signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
531	Ras signaling pathway 💬	[3] GRIN1, GRIN2A, GRIN2B 💬 Ras signaling pathway × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Riluzole 💬 Ras signaling pathway × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 531. Ras signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
532	Regulation of actin cytoskeleton 💬	[2] PDGFRA, PDGFRB 💬 Regulation of actin cytoskeleton × Name Full Name PDGFRA platelet derived growth factor receptor alpha PDGFRB platelet derived growth factor receptor beta	Nilotinib 💬 Regulation of actin cytoskeleton × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 532. Regulation of actin cytoskeleton × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
533	Regulation of lipolysis in adipocytes 💬	[1] ADRB1 💬 Regulation of lipolysis in adipocytes × Name Full Name ADRB1 adrenoceptor beta 1	Bevantolol hydrochloride 💬 Regulation of lipolysis in adipocytes × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 533. Regulation of lipolysis in adipocytes × Disease ID Name  8  Huntington disease;Huntington chorea;
534	Relaxin signaling pathway 💬	[4] P38, P38, P38, P38 💬 Relaxin signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Relaxin signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 534. Relaxin signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
535	Renin secretion 💬	[5] ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Renin secretion × Name Full Name ADRB1 adrenoceptor beta 1 CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Renin secretion × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 535. Renin secretion × Disease ID Name  8  Huntington disease;Huntington chorea;
536	Retrograde endocannabinoid signaling 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Retrograde endocannabinoid signaling × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Retrograde endocannabinoid signaling × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 536. Retrograde endocannabinoid signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
537	Retrograde endocannabinoid signaling 💬	[1] CNR1 💬 Retrograde endocannabinoid signaling × Name Full Name CNR1 cannabinoid receptor 1	Cannabidiol 💬 Retrograde endocannabinoid signaling × Name Other Names Cannabidiol Cannabidiol (JAN/USAN/INN) CBD Epidiolex (TN) EPIDIOLEX	Cannabidiol	[20]  6 ,  8 , 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 537. Retrograde endocannabinoid signaling × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 36 Epidermolysis bullosa;Kindler syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 95 Autoimmune hepatitis; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 140 Dorabe syndrome;Dravet syndrome; 144 Lennox-Gastaut syndrome; 145 West syndrome;Infantile spasm;Infantile spasms;Infantile spasms syndrome;Infantile epileptic spasms;Infantile epileptic spasms syndrome; 156 Rett syndrome; 157 Sturge-Weber syndrome;Síndrome de Sturge-Weber; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 193 Prader-Willi syndrome; 206 Fragile X syndrome; 226 Interstitial cystitis with Hunners ulcer;Interstitial cystitis; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica;
538	Retrograde endocannabinoid signaling 💬	[1] CNR1 💬 Retrograde endocannabinoid signaling × Name Full Name CNR1 cannabinoid receptor 1	Dronabinol 💬 Retrograde endocannabinoid signaling × Name Other Names Dronabinol Dronabinol (USP/INN) Tetrahydrocannabinol THC Marinol (TN) DRONABINOL MARINOL SYNDROS	Dronabinol	[8]  2 ,  8 , 13, 36, 46, 96, 271, 298 💬 538. Retrograde endocannabinoid signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 36 Epidermolysis bullosa;Kindler syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 298 Hereditary pancreatitis;Chronic pancreatitis;
539	Retrograde endocannabinoid signaling 💬	[16] GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Retrograde endocannabinoid signaling × Name Full Name GABRA GABRA GABRA GABRA GABRA GABRA GABRB GABRB GABRB GABRD gamma-aminobutyric acid type A receptor subunit delta GABRE gamma-aminobutyric acid type A receptor subunit epsilon GABRG GABRG GABRG GABRP gamma-aminobutyric acid type A receptor subunit pi GABRQ gamma-aminobutyric acid type A receptor subunit theta	Alprazolam 💬 Retrograde endocannabinoid signaling × Name Other Names Alprazolam Alprazolam (JP18/USP/INN) Xanax (TN) XANAX ALPRAZOLAM ALPRAZOLAM C-IV	Alprazolam	[2]  8 , 75 💬 539. Retrograde endocannabinoid signaling × Disease ID Name  8  Huntington disease;Huntington chorea; 75 Cushing disease;Cushing syndrome;
540	Retrograde endocannabinoid signaling 💬	[4] GRIA1, GRIA2, GRIA3, GRIA4 💬 Retrograde endocannabinoid signaling × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIA3 glutamate ionotropic receptor AMPA type subunit 3 GRIA4 glutamate ionotropic receptor AMPA type subunit 4	Riluzole 💬 Retrograde endocannabinoid signaling × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 540. Retrograde endocannabinoid signaling × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
541	Retrograde endocannabinoid signaling 💬	[4] P38, P38, P38, P38 💬 Retrograde endocannabinoid signaling × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Retrograde endocannabinoid signaling × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 541. Retrograde endocannabinoid signaling × Disease ID Name  8  Huntington disease;Huntington chorea;
542	RIG-I-like receptor signaling pathway 💬	[4] P38, P38, P38, P38 💬 RIG-I-like receptor signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 RIG-I-like receptor signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 542. RIG-I-like receptor signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
543	Salivary secretion 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬 Salivary secretion × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D	Olanzapine 💬 Salivary secretion × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 543. Salivary secretion × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
544	Salivary secretion 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬 Salivary secretion × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D	Olanzapine pamoate 💬 Salivary secretion × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 543. Salivary secretion × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
545	Salivary secretion 💬	[4] ADRA1A, ADRA1B, ADRA1D, ADRB1 💬 Salivary secretion × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1	Bevantolol hydrochloride 💬 Salivary secretion × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 545. Salivary secretion × Disease ID Name  8  Huntington disease;Huntington chorea;
546	Salivary secretion 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Salivary secretion × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Salivary secretion × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 546. Salivary secretion × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
547	Salmonella infection 💬	[4] P38, P38, P38, P38 💬 Salmonella infection × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Salmonella infection × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 547. Salmonella infection × Disease ID Name  8  Huntington disease;Huntington chorea;
548	Serotonergic synapse 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Serotonergic synapse × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Serotonergic synapse × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 548. Serotonergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
549	Serotonergic synapse 💬	[3] GABRB, GABRB, GABRB 💬 Serotonergic synapse × Name Full Name GABRB GABRB GABRB	Alprazolam 💬 Serotonergic synapse × Name Other Names Alprazolam Alprazolam (JP18/USP/INN) Xanax (TN) XANAX ALPRAZOLAM ALPRAZOLAM C-IV	Alprazolam	[2]  8 , 75 💬 549. Serotonergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea; 75 Cushing disease;Cushing syndrome;
550	Serotonergic synapse 💬	[1] HTR2 💬 Serotonergic synapse × Name Full Name HTR2	Risperidone 💬 Serotonergic synapse × Name Other Names Risperidone Risperidone (JP18/USP/INN) Risperdal (TN) PERSERIS RISPERDAL CONSTA RISPERIDONE RYKINDO UZEDY	Risperidone	[3]  8 , 156, 187 💬 550. Serotonergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea; 156 Rett syndrome; 187 Kabuki syndrome;
551	Serotonergic synapse 💬	[4] HTR2, HTR2, HTR2, HTR6 💬 Serotonergic synapse × Name Full Name HTR2 HTR2 HTR2 HTR6 5-hydroxytryptamine receptor 6	Olanzapine pamoate 💬 Serotonergic synapse × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 551. Serotonergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
552	Serotonergic synapse 💬	[4] HTR2, HTR2, HTR2, HTR6 💬 Serotonergic synapse × Name Full Name HTR2 HTR2 HTR2 HTR6 5-hydroxytryptamine receptor 6	Olanzapine 💬 Serotonergic synapse × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 551. Serotonergic synapse × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
553	Serotonergic synapse 💬	[1] SLC18A1_2 💬 Serotonergic synapse × Name Full Name SLC18A1_2	Deutetrabenazine 💬 Serotonergic synapse × Name Other Names Deutetrabenazine Deutetrabenazine (USAN/INN) Austedo (TN) DEUTETRABENAZINE	Deutetrabenazine	[1]  8  💬 553. Serotonergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
554	Serotonergic synapse 💬	[1] SLC18A1_2 💬 Serotonergic synapse × Name Full Name SLC18A1_2	Tetrabenazine 💬 Serotonergic synapse × Name Other Names Tetrabenazine Tetrabenazine (JAN/INN) Nitoman (TN) Xenazine (TN) XENAZINE TETRABENAZINE	Tetrabenazine	[1]  8  💬 554. Serotonergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
555	Serotonergic synapse 💬	[1] SLC18A1_2 💬 Serotonergic synapse × Name Full Name SLC18A1_2	Valbenazine 💬 Serotonergic synapse × Name Other Names Valbenazine Valbenazine (USAN/INN)	Valbenazine	[1]  8  💬 555. Serotonergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
556	Serotonergic synapse 💬	[1] SLC18A1_2 💬 Serotonergic synapse × Name Full Name SLC18A1_2	Valbenazine tosylate 💬 Serotonergic synapse × Name Other Names Valbenazine tosylate Valbenazine tosylate (USAN) Valbenazine tosilate (JAN) Valbenazine ditosylate Ingrezza (TN) Dysval (TN) VALBENAZINE	Valbenazine	[1]  8  💬 555. Serotonergic synapse × Disease ID Name  8  Huntington disease;Huntington chorea;
557	Shigellosis 💬	[4] P38, P38, P38, P38 💬 Shigellosis × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Shigellosis × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 557. Shigellosis × Disease ID Name  8  Huntington disease;Huntington chorea;
558	Signaling pathways regulating pluripotency of stem cells 💬	[4] P38, P38, P38, P38 💬 Signaling pathways regulating pluripotency of stem cells × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Signaling pathways regulating pluripotency of stem cells × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 558. Signaling pathways regulating pluripotency of stem cells × Disease ID Name  8  Huntington disease;Huntington chorea;
559	Sphingolipid signaling pathway 💬	[4] P38, P38, P38, P38 💬 Sphingolipid signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Sphingolipid signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 559. Sphingolipid signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
560	Spinocerebellar ataxia 💬	[8] GRIA1, GRIA2, GRIA3, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Spinocerebellar ataxia × Name Full Name GRIA1 glutamate ionotropic receptor AMPA type subunit 1 GRIA2 glutamate ionotropic receptor AMPA type subunit 2 GRIA3 glutamate ionotropic receptor AMPA type subunit 3 GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Riluzole 💬 Spinocerebellar ataxia × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 560. Spinocerebellar ataxia × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
561	Spinocerebellar ataxia 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Spinocerebellar ataxia × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine hydrochloride 💬 Spinocerebellar ataxia × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 561. Spinocerebellar ataxia × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
562	Spinocerebellar ataxia 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Spinocerebellar ataxia × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Amantadine 💬 Spinocerebellar ataxia × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 561. Spinocerebellar ataxia × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
563	Spinocerebellar ataxia 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Spinocerebellar ataxia × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan hydrobromide 💬 Spinocerebellar ataxia × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 563. Spinocerebellar ataxia × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
564	Spinocerebellar ataxia 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Spinocerebellar ataxia × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Dextromethorphan 💬 Spinocerebellar ataxia × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 563. Spinocerebellar ataxia × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
565	Spinocerebellar ataxia 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Spinocerebellar ataxia × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine 💬 Spinocerebellar ataxia × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 565. Spinocerebellar ataxia × Disease ID Name  8  Huntington disease;Huntington chorea;
566	Spinocerebellar ataxia 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Spinocerebellar ataxia × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Latrepirdine dihydrochloride 💬 Spinocerebellar ataxia × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 565. Spinocerebellar ataxia × Disease ID Name  8  Huntington disease;Huntington chorea;
567	Spinocerebellar ataxia 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Spinocerebellar ataxia × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine hydrochloride 💬 Spinocerebellar ataxia × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 567. Spinocerebellar ataxia × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
568	Spinocerebellar ataxia 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 Spinocerebellar ataxia × Name Full Name GRIN1 glutamate ionotropic receptor NMDA type subunit 1 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B GRIN2C glutamate ionotropic receptor NMDA type subunit 2C GRIN2D glutamate ionotropic receptor NMDA type subunit 2D	Memantine 💬 Spinocerebellar ataxia × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 567. Spinocerebellar ataxia × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
569	Synaptic vesicle cycle 💬	[1] SLC18A1_2 💬 Synaptic vesicle cycle × Name Full Name SLC18A1_2	Deutetrabenazine 💬 Synaptic vesicle cycle × Name Other Names Deutetrabenazine Deutetrabenazine (USAN/INN) Austedo (TN) DEUTETRABENAZINE	Deutetrabenazine	[1]  8  💬 569. Synaptic vesicle cycle × Disease ID Name  8  Huntington disease;Huntington chorea;
570	Synaptic vesicle cycle 💬	[1] SLC18A1_2 💬 Synaptic vesicle cycle × Name Full Name SLC18A1_2	Tetrabenazine 💬 Synaptic vesicle cycle × Name Other Names Tetrabenazine Tetrabenazine (JAN/INN) Nitoman (TN) Xenazine (TN) XENAZINE TETRABENAZINE	Tetrabenazine	[1]  8  💬 570. Synaptic vesicle cycle × Disease ID Name  8  Huntington disease;Huntington chorea;
571	Synaptic vesicle cycle 💬	[1] SLC18A1_2 💬 Synaptic vesicle cycle × Name Full Name SLC18A1_2	Valbenazine 💬 Synaptic vesicle cycle × Name Other Names Valbenazine Valbenazine (USAN/INN)	Valbenazine	[1]  8  💬 571. Synaptic vesicle cycle × Disease ID Name  8  Huntington disease;Huntington chorea;
572	Synaptic vesicle cycle 💬	[1] SLC18A1_2 💬 Synaptic vesicle cycle × Name Full Name SLC18A1_2	Valbenazine tosylate 💬 Synaptic vesicle cycle × Name Other Names Valbenazine tosylate Valbenazine tosylate (USAN) Valbenazine tosilate (JAN) Valbenazine ditosylate Ingrezza (TN) Dysval (TN) VALBENAZINE	Valbenazine	[1]  8  💬 571. Synaptic vesicle cycle × Disease ID Name  8  Huntington disease;Huntington chorea;
573	Synaptic vesicle cycle 💬	[1] SLC6A2 💬 Synaptic vesicle cycle × Name Full Name SLC6A2 solute carrier family 6 member 2	Atomoxetine hydrochloride 💬 Synaptic vesicle cycle × Name Other Names Atomoxetine hydrochloride Atomoxetine hydrochloride (JAN/USP) Tomoxetine hydrochloride Strattera (TN) STRATTERA ATOMOXETINE ATOMOXETINE HYDROCHLORIDE	Atomoxetine	[4]  6 ,  8 , 13, 230 💬 573. Synaptic vesicle cycle × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 230 Alveolar hypoventilation syndrome;AHS;Hypoventilation syndrome;
574	Synaptic vesicle cycle 💬	[1] SLC6A2 💬 Synaptic vesicle cycle × Name Full Name SLC6A2 solute carrier family 6 member 2	Atomoxetine 💬 Synaptic vesicle cycle × Name Other Names Atomoxetine Atomoxetine (USP/INN) Tomoxetine	Atomoxetine	[4]  6 ,  8 , 13, 230 💬 573. Synaptic vesicle cycle × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 230 Alveolar hypoventilation syndrome;AHS;Hypoventilation syndrome;
575	Synaptic vesicle cycle 💬	[2] SLC6A2, SLC6A3 💬 Synaptic vesicle cycle × Name Full Name SLC6A2 solute carrier family 6 member 2 SLC6A3 solute carrier family 6 member 3	Bupropion hydrochloride 💬 Synaptic vesicle cycle × Name Other Names Bupropion hydrochloride Bupropion hydrochloride (JAN/USP) Wellbutrin (TN) Zyban (TN) FORFIVO WELLBUTRIN BUPROPION BUPROPION HCL BUPROPION HCL ER BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE SR	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 575. Synaptic vesicle cycle × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
576	Synaptic vesicle cycle 💬	[2] SLC6A2, SLC6A3 💬 Synaptic vesicle cycle × Name Full Name SLC6A2 solute carrier family 6 member 2 SLC6A3 solute carrier family 6 member 3	Bupropion 💬 Synaptic vesicle cycle × Name Other Names Bupropion Bupropion (INN)	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 575. Synaptic vesicle cycle × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
577	Synaptic vesicle cycle 💬	[2] SLC6A2, SLC6A3 💬 Synaptic vesicle cycle × Name Full Name SLC6A2 solute carrier family 6 member 2 SLC6A3 solute carrier family 6 member 3	Bupropion hydrobromide 💬 Synaptic vesicle cycle × Name Other Names Bupropion hydrobromide Bupropion hydrobromide (USAN) Aplenzin (TN) APLENZIN	Bupropion	[6]  8 , 18, 21, 96, 97, 171 💬 575. Synaptic vesicle cycle × Disease ID Name  8  Huntington disease;Huntington chorea; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 171 Wilson disease;WD;
578	Systemic lupus erythematosus 💬	[2] GRIN2A, GRIN2B 💬 Systemic lupus erythematosus × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Amantadine hydrochloride 💬 Systemic lupus erythematosus × Name Other Names Amantadine hydrochloride Amantadine hydrochloride (JP18/USP) Symmetrel (TN) Gocovri (TN) Osmolex er (TN) GOCOVRI AMANTADINE AMANTADINE HCL AMANTADINE HYDROCHLORIDE	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 578. Systemic lupus erythematosus × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
579	Systemic lupus erythematosus 💬	[2] GRIN2A, GRIN2B 💬 Systemic lupus erythematosus × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Amantadine 💬 Systemic lupus erythematosus × Name Other Names Amantadine Amantadine (INN)	Amantadine	[5]  2 ,  6 ,  8 , 13, 127 💬 578. Systemic lupus erythematosus × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia;
580	Systemic lupus erythematosus 💬	[2] GRIN2A, GRIN2B 💬 Systemic lupus erythematosus × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Dextromethorphan hydrobromide 💬 Systemic lupus erythematosus × Name Other Names Dextromethorphan hydrobromide Dextromethorphan hydrobromide (USP) Dextromethorphan hydrobromide hydrate (JP18) Benylin DM (TN)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 580. Systemic lupus erythematosus × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
581	Systemic lupus erythematosus 💬	[2] GRIN2A, GRIN2B 💬 Systemic lupus erythematosus × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Dextromethorphan 💬 Systemic lupus erythematosus × Name Other Names Dextromethorphan Dextromethorphan (USP)	Dextromethorphan	[10]  2 ,  6 ,  8 , 13, 21, 46, 85, 96, 97, 156 💬 580. Systemic lupus erythematosus × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 156 Rett syndrome;
582	Systemic lupus erythematosus 💬	[2] GRIN2A, GRIN2B 💬 Systemic lupus erythematosus × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Latrepirdine 💬 Systemic lupus erythematosus × Name Other Names Latrepirdine Latrepirdine (USAN/INN)	Latrepirdine	[1]  8  💬 582. Systemic lupus erythematosus × Disease ID Name  8  Huntington disease;Huntington chorea;
583	Systemic lupus erythematosus 💬	[2] GRIN2A, GRIN2B 💬 Systemic lupus erythematosus × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Latrepirdine dihydrochloride 💬 Systemic lupus erythematosus × Name Other Names Latrepirdine dihydrochloride Latrepirdine dihydrochloride (USAN) Dimebolin Dimebon	Latrepirdine	[1]  8  💬 582. Systemic lupus erythematosus × Disease ID Name  8  Huntington disease;Huntington chorea;
584	Systemic lupus erythematosus 💬	[2] GRIN2A, GRIN2B 💬 Systemic lupus erythematosus × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Memantine hydrochloride 💬 Systemic lupus erythematosus × Name Other Names Memantine hydrochloride Memantine hydrochloride (JAN/USP) Namenda (TN) Memary (TN) MEMANTINE HYDROCHLORIDE NAMENDA MEMANTINE MEMANTINE HCL	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 584. Systemic lupus erythematosus × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
585	Systemic lupus erythematosus 💬	[2] GRIN2A, GRIN2B 💬 Systemic lupus erythematosus × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Memantine 💬 Systemic lupus erythematosus × Name Other Names Memantine Memantine (INN) Exiba (TN)	Memantine	[8]  2 ,  6 ,  8 , 13, 49, 127, 205, 206 💬 584. Systemic lupus erythematosus × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 49 Systemic lupus erythematosus;SLE; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 205 Fragile X syndrome related disease;Fragile X-associated tremor/ataxia syndrome;FXTAS;Fragile X-associated tremor;Ataxia syndrome; 206 Fragile X syndrome;
586	Systemic lupus erythematosus 💬	[2] GRIN2A, GRIN2B 💬 Systemic lupus erythematosus × Name Full Name GRIN2A glutamate ionotropic receptor NMDA type subunit 2A GRIN2B glutamate ionotropic receptor NMDA type subunit 2B	Riluzole 💬 Systemic lupus erythematosus × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 586. Systemic lupus erythematosus × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
587	T cell receptor signaling pathway 💬	[4] P38, P38, P38, P38 💬 T cell receptor signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 T cell receptor signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 587. T cell receptor signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
588	Taste transduction 💬	[1] CACNA1C 💬 Taste transduction × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C	Bevantolol hydrochloride 💬 Taste transduction × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 588. Taste transduction × Disease ID Name  8  Huntington disease;Huntington chorea;
589	Taste transduction 💬	[6] GABRA, GABRA, GABRA, GABRA, GABRA, GABRA 💬 Taste transduction × Name Full Name GABRA GABRA GABRA GABRA GABRA GABRA	Alprazolam 💬 Taste transduction × Name Other Names Alprazolam Alprazolam (JP18/USP/INN) Xanax (TN) XANAX ALPRAZOLAM ALPRAZOLAM C-IV	Alprazolam	[2]  8 , 75 💬 589. Taste transduction × Disease ID Name  8  Huntington disease;Huntington chorea; 75 Cushing disease;Cushing syndrome;
590	Taste transduction 💬	[3] SCN2A, SCN3A, SCN9A 💬 Taste transduction × Name Full Name SCN2A sodium voltage-gated channel alpha subunit 2 SCN3A sodium voltage-gated channel alpha subunit 3 SCN9A sodium voltage-gated channel alpha subunit 9	Quinidine gluconate 💬 Taste transduction × Name Other Names Quinidine gluconate Quinidine gluconate (USP) Quinaglute (TN)	Quinidine	[2]  8 , 13 💬 590. Taste transduction × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
591	Taste transduction 💬	[3] SCN2A, SCN3A, SCN9A 💬 Taste transduction × Name Full Name SCN2A sodium voltage-gated channel alpha subunit 2 SCN3A sodium voltage-gated channel alpha subunit 3 SCN9A sodium voltage-gated channel alpha subunit 9	Quinidine polygalacturonate 💬 Taste transduction × Name Other Names Quinidine polygalacturonate Quinidine polygalacturonate Cardioquin (TN)	Quinidine	[2]  8 , 13 💬 590. Taste transduction × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
592	Taste transduction 💬	[3] SCN2A, SCN3A, SCN9A 💬 Taste transduction × Name Full Name SCN2A sodium voltage-gated channel alpha subunit 2 SCN3A sodium voltage-gated channel alpha subunit 3 SCN9A sodium voltage-gated channel alpha subunit 9	Quinidine sulfate 💬 Taste transduction × Name Other Names Quinidine sulfate Quinidine sulfate (USP) Quinidine sulfate hydrate (JP18) Quinidex (TN)	Quinidine	[2]  8 , 13 💬 590. Taste transduction × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
593	Taste transduction 💬	[3] SCN2A, SCN3A, SCN9A 💬 Taste transduction × Name Full Name SCN2A sodium voltage-gated channel alpha subunit 2 SCN3A sodium voltage-gated channel alpha subunit 3 SCN9A sodium voltage-gated channel alpha subunit 9	Quinidine 💬 Taste transduction × Name Other Names Quinidine Quinidine (BAN) Kinidin (TN)	Quinidine	[2]  8 , 13 💬 590. Taste transduction × Disease ID Name  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis;
594	Th1 and Th2 cell differentiation 💬	[4] P38, P38, P38, P38 💬 Th1 and Th2 cell differentiation × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Th1 and Th2 cell differentiation × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 594. Th1 and Th2 cell differentiation × Disease ID Name  8  Huntington disease;Huntington chorea;
595	Th17 cell differentiation 💬	[4] P38, P38, P38, P38 💬 Th17 cell differentiation × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Th17 cell differentiation × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 595. Th17 cell differentiation × Disease ID Name  8  Huntington disease;Huntington chorea;
596	Thermogenesis 💬	[1] CNR1 💬 Thermogenesis × Name Full Name CNR1 cannabinoid receptor 1	Cannabidiol 💬 Thermogenesis × Name Other Names Cannabidiol Cannabidiol (JAN/USAN/INN) CBD Epidiolex (TN) EPIDIOLEX	Cannabidiol	[20]  6 ,  8 , 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 596. Thermogenesis × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 36 Epidermolysis bullosa;Kindler syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 95 Autoimmune hepatitis; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 140 Dorabe syndrome;Dravet syndrome; 144 Lennox-Gastaut syndrome; 145 West syndrome;Infantile spasm;Infantile spasms;Infantile spasms syndrome;Infantile epileptic spasms;Infantile epileptic spasms syndrome; 156 Rett syndrome; 157 Sturge-Weber syndrome;Síndrome de Sturge-Weber; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 193 Prader-Willi syndrome; 206 Fragile X syndrome; 226 Interstitial cystitis with Hunners ulcer;Interstitial cystitis; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica;
597	Thermogenesis 💬	[1] CNR1 💬 Thermogenesis × Name Full Name CNR1 cannabinoid receptor 1	Dronabinol 💬 Thermogenesis × Name Other Names Dronabinol Dronabinol (USP/INN) Tetrahydrocannabinol THC Marinol (TN) DRONABINOL MARINOL SYNDROS	Dronabinol	[8]  2 ,  8 , 13, 36, 46, 96, 271, 298 💬 597. Thermogenesis × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 36 Epidermolysis bullosa;Kindler syndrome; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 298 Hereditary pancreatitis;Chronic pancreatitis;
598	Thermogenesis 💬	[4] P38, P38, P38, P38 💬 Thermogenesis × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Thermogenesis × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 598. Thermogenesis × Disease ID Name  8  Huntington disease;Huntington chorea;
599	Thermogenesis 💬	[2] PRKAA, PRKAA 💬 Thermogenesis × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Thermogenesis × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 599. Thermogenesis × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
600	Thermogenesis 💬	[2] PRKAA, PRKAA 💬 Thermogenesis × Name Full Name PRKAA PRKAA	Metformin 💬 Thermogenesis × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 599. Thermogenesis × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
601	Thyroid hormone signaling pathway 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Thyroid hormone signaling pathway × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Thyroid hormone signaling pathway × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 601. Thyroid hormone signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
602	Thyroid hormone synthesis 💬	[4] ATP1A, ATP1A, ATP1A, ATP1A 💬 Thyroid hormone synthesis × Name Full Name ATP1A ATP1A ATP1A ATP1A	Digoxin 💬 Thyroid hormone synthesis × Name Other Names Digoxin Digoxin (JP18/USP) Lanoxicaps (TN) Lanoxin (TN) DIGOXIN LANOXIN	Digoxin	[3]  8 , 46, 210 💬 602. Thyroid hormone synthesis × Disease ID Name  8  Huntington disease;Huntington chorea; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 210 Single Ventricle;SV;Single ventricle heart defect;Univentricular heart;UVH;Single ventricular circulation syndrome;
603	Tight junction 💬	[1] CACNA1D 💬 Tight junction × Name Full Name CACNA1D calcium voltage-gated channel subunit alpha1 D	Bevantolol hydrochloride 💬 Tight junction × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 603. Tight junction × Disease ID Name  8  Huntington disease;Huntington chorea;
604	Tight junction 💬	[2] PRKAA, PRKAA 💬 Tight junction × Name Full Name PRKAA PRKAA	Metformin 💬 Tight junction × Name Other Names Metformin Metformin (USAN/INN)	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 604. Tight junction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
605	Tight junction 💬	[2] PRKAA, PRKAA 💬 Tight junction × Name Full Name PRKAA PRKAA	Metformin hydrochloride 💬 Tight junction × Name Other Names Metformin hydrochloride Metformin hydrochloride (JP18/USP) Glucophage (TN) GLUMETZA RIOMET METFORMIN METFORMIN ER 500 MG METFORMIN HCL METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE EXTENDED RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG METFORMIN HYDROCHLORIDE ORAL SOLUTION	Metformin	[28]  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬 604. Tight junction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 60 Aplastic anemia; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 75 Cushing disease;Cushing syndrome; 77 Growth hormone secreting pituitary adenoma;Pituitary growth hormone secretion hyperthyroidism;Acromegaly; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 86 Pulmonary arterial hypertension;PAH; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 206 Fragile X syndrome; 218 Alport syndrome; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 225 Congenital nephrogenic diabetes insipidus;Hereditary nephrogenic diabetes insipidus;Nephrogenic diabetes insipidus; 265 Lipodystrophy; 285 Fanconi anemia; 298 Hereditary pancreatitis;Chronic pancreatitis; 299 Cystic fibrosis;CF; 301 Macular dystrophy;Vitelliform macular dystrophy;Best vitelliform macular dystrophy;Best disease;Stargardt disease;Occult macular dystrophy;Cone dystrophy;Cone rod dystrophy;X-linked juvenile retinoschisis;Central areolar choroidal dystrophy;
606	TNF signaling pathway 💬	[4] P38, P38, P38, P38 💬 TNF signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 TNF signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 606. TNF signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
607	Toll-like receptor signaling pathway 💬	[4] P38, P38, P38, P38 💬 Toll-like receptor signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Toll-like receptor signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 607. Toll-like receptor signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
608	Toxoplasmosis 💬	[4] P38, P38, P38, P38 💬 Toxoplasmosis × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Toxoplasmosis × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 608. Toxoplasmosis × Disease ID Name  8  Huntington disease;Huntington chorea;
609	Transcriptional misregulation in cancer 💬	[1] GRIA3 💬 Transcriptional misregulation in cancer × Name Full Name GRIA3 glutamate ionotropic receptor AMPA type subunit 3	Riluzole 💬 Transcriptional misregulation in cancer × Name Other Names Riluzole Riluzole (JAN/USP/INN) Rilutek (TN) TIGLUTIK RILUZOLE	Riluzole	[8]  2 ,  3 ,  5 ,  8 , 13, 17, 203, 206 💬 609. Transcriptional misregulation in cancer × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  5  Progressive supranuclear palsy;PSP;  8  Huntington disease;Huntington chorea; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 17 Multiple system atrophy;MSA;MSA;Olivopontocerebellar atrophy;OPCA;Striatonigral degeneration;Shy-Drager syndrome; 203 22q11.2 deletion syndrome; 206 Fragile X syndrome;
610	Tuberculosis 💬	[4] P38, P38, P38, P38 💬 Tuberculosis × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Tuberculosis × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 610. Tuberculosis × Disease ID Name  8  Huntington disease;Huntington chorea;
611	Type II diabetes mellitus 💬	[2] CACNA1C, CACNA1D 💬 Type II diabetes mellitus × Name Full Name CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D	Bevantolol hydrochloride 💬 Type II diabetes mellitus × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 611. Type II diabetes mellitus × Disease ID Name  8  Huntington disease;Huntington chorea;
612	Ubiquinone and other terpenoid-quinone biosynthesis 💬	[2] NQO1, VKORC1 💬 Ubiquinone and other terpenoid-quinone biosynthesis × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1 VKORC1 vitamin K epoxide reductase complex subunit 1	Warfarin sodium 💬 Ubiquinone and other terpenoid-quinone biosynthesis × Name Other Names Warfarin sodium Warfarin sodium (USP) Coumadin (TN) Jantoven (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 612. Ubiquinone and other terpenoid-quinone biosynthesis × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
613	Ubiquinone and other terpenoid-quinone biosynthesis 💬	[2] NQO1, VKORC1 💬 Ubiquinone and other terpenoid-quinone biosynthesis × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1 VKORC1 vitamin K epoxide reductase complex subunit 1	Warfarin potassium 💬 Ubiquinone and other terpenoid-quinone biosynthesis × Name Other Names Warfarin potassium Warfarin potassium (JP18) Athrombin-K (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 612. Ubiquinone and other terpenoid-quinone biosynthesis × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
614	Ubiquinone and other terpenoid-quinone biosynthesis 💬	[2] NQO1, VKORC1 💬 Ubiquinone and other terpenoid-quinone biosynthesis × Name Full Name NQO1 NAD(P)H quinone dehydrogenase 1 VKORC1 vitamin K epoxide reductase complex subunit 1	Warfarin 💬 Ubiquinone and other terpenoid-quinone biosynthesis × Name Other Names Warfarin Warfarin (INN) Warfarine Choice (TN)	Warfarin	[12]  6 ,  8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬 612. Ubiquinone and other terpenoid-quinone biosynthesis × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 88 Chronic thromboembolic pulmonary hypertension;CTEPH;Idiopathic chronic pulmonary thromboembolism; 91 Budd-Chiari syndrome;BCS; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD;
615	Vascular smooth muscle contraction 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬 Vascular smooth muscle contraction × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D	Olanzapine 💬 Vascular smooth muscle contraction × Name Other Names Olanzapine Olanzapine (JAN/USP/INN) Zyprexa (TN) ZYPREXA OLANZAPINE	Olanzapine	[2]  2 ,  8  💬 615. Vascular smooth muscle contraction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
616	Vascular smooth muscle contraction 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬 Vascular smooth muscle contraction × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D	Olanzapine pamoate 💬 Vascular smooth muscle contraction × Name Other Names Olanzapine pamoate Olanzapine pamoate (USAN) Olanzapine pamoate monohydrate Zyprexa (TN) ZYPREXA	Olanzapine	[2]  2 ,  8  💬 615. Vascular smooth muscle contraction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  8  Huntington disease;Huntington chorea;
617	Vascular smooth muscle contraction 💬	[7] ADRA1A, ADRA1B, ADRA1D, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Vascular smooth muscle contraction × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D CACNA1C calcium voltage-gated channel subunit alpha1 C CACNA1D calcium voltage-gated channel subunit alpha1 D CACNA1F calcium voltage-gated channel subunit alpha1 F CACNA1S calcium voltage-gated channel subunit alpha1 S	Bevantolol hydrochloride 💬 Vascular smooth muscle contraction × Name Other Names Bevantolol hydrochloride Bevantolol hydrochloride (JAN/USAN) Calvan (TN) Vantol (TN)	Bevantolol	[1]  8  💬 617. Vascular smooth muscle contraction × Disease ID Name  8  Huntington disease;Huntington chorea;
618	VEGF signaling pathway 💬	[4] P38, P38, P38, P38 💬 VEGF signaling pathway × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 VEGF signaling pathway × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 618. VEGF signaling pathway × Disease ID Name  8  Huntington disease;Huntington chorea;
619	Viral myocarditis 💬	[1] ABL1 💬 Viral myocarditis × Name Full Name ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase	Nilotinib 💬 Viral myocarditis × Name Other Names Nilotinib Nilotinib (USAN/INN)	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬 619. Viral myocarditis × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH;
620	Yersinia infection 💬	[4] P38, P38, P38, P38 💬 Yersinia infection × Name Full Name P38 P38 P38 P38	Neflamapimod 💬 Yersinia infection × Name Other Names Neflamapimod Neflamapimod (USAN/INN)	Neflamapimod	[1]  8  💬 620. Yersinia infection × Disease ID Name  8  Huntington disease;Huntington chorea;

Back to top